Term,fdr,fdr
Cap-dependent Translation Initiation ,0.0,0.9434435246699506
Eukaryotic Translation Elongation ,0.0,0.9647866302638056
Eukaryotic Translation Initiation ,0.0,0.9369337792600116
Eukaryotic Translation Termination ,0.0,0.9184201119980936
Formation of a pool of free 40S subunits ,0.0,0.8309298041408133
GTP hydrolysis and joining of the 60S ribosomal subunit ,0.0,0.9377908053518232
L13a-mediated translational silencing of Ceruloplasmin expression ,0.0,0.916228073904652
Major pathway of rRNA processing in the nucleolus and cytosol ,0.0,0.8279952965013898
Mitochondrial translation elongation ,0.0,1.0
Mitochondrial translation termination ,0.0,1.0
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) ,0.0,0.9652460093682299
Peptide chain elongation ,0.0,0.965883693924388
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. ",0.0,0.8335352173500881
Response of EIF2AK4 (GCN2) to amino acid deficiency ,0.0,0.962025921551016
SRP-dependent cotranslational protein targeting to membrane ,0.0,0.942071030415034
Selenoamino acid metabolism ,0.0,0.9661012886711268
Selenocysteine synthesis ,0.0,0.963173145163572
Translation ,0.0,0.8431375897549748
Viral mRNA Translation ,0.0,0.9634348747202922
rRNA processing ,0.0,0.8273819421544567
rRNA processing in the nucleus and cytosol ,0.0,0.8314549188755257
Mitochondrial translation ,3.991519304316461e-05,1.0
Respiratory electron transport ,4.165063621895437e-05,0.8312825205138379
The citric acid (TCA) cycle and respiratory electron transport ,4.3543846956179574e-05,0.3552727506021918
Influenza Viral RNA Transcription and Replication ,7.663717064287604e-05,0.8436026025684074
Cristae formation ,0.00014192068637569637,0.9791807144362846
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S ",0.00014737917431322317,0.9641665512189962
"Formation of the ternary complex, and subsequently, the 43S complex ",0.000171065113042134,0.9315797838525112
Mitochondrial translation initiation ,0.0001981995792488173,1.0
Metabolism of RNA ,0.000798303860863292,0.6848811147420204
Influenza Life Cycle ,0.0010477738173830706,0.8294122660777871
Regulation of expression of SLITs and ROBOs ,0.0010506708878458813,1.0
Formation of ATP by chemiosmotic coupling ,0.001190198483468908,0.955291527058322
Influenza Infection ,0.0012864096500768475,0.9177776615562724
Nonsense-Mediated Decay (NMD) ,0.0013242452280202847,0.8778232793609457
Ribosomal scanning and start codon recognition ,0.0014103368208584824,0.9648022925087144
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) ,0.0016829108418199127,0.8796785560774797
Interconversion of nucleotide di- and triphosphates ,0.0028738938991078517,0.8326019642101429
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers ,0.0031151011924176173,1.0
Mitochondrial protein import ,0.0038564217278626725,0.9740126284997452
Interleukin-2 family signaling ,0.004153468256556822,1.0
Signaling by ROBO receptors ,0.004286891732835878,0.9133067299672804
Translation initiation complex formation ,0.004672998209931466,0.9631751519537036
Complex I biogenesis ,0.007321586838203335,0.8274205859304032
Metabolism ,0.007440934591488545,0.0
MET activates PTK2 signaling ,0.010428751346005004,1.0
Metabolism of amino acids and derivatives ,0.011410423184605988,0.4774716976551839
"Interleukin-3, Interleukin-5 and GM-CSF signaling ",0.012757081073710241,1.0
FCGR activation ,0.014166293517899163,1.0
Interleukin-35 Signalling ,0.014191016543235813,0.8213958007002599
HDACs deacetylate histones ,0.014537138897948878,1.0
Initial triggering of complement ,0.01461701328749805,1.0
Metabolism of proteins ,0.014744325221509846,0.11986484463548686
VEGFR2 mediated vascular permeability ,0.015171696548256172,1.0
Interleukin-15 signaling ,0.015192949675299956,0.9766423997645816
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell ,0.015367832549260245,1.0
Costimulation by the CD28 family ,0.015386711950426412,1.0
DNA methylation ,0.015488975373409819,0.9577831573948424
RNA Polymerase I Promoter Opening ,0.015941988455313687,0.9686625173120328
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 ,0.016159587435666388,0.8277768253704484
PRC2 methylates histones and DNA ,0.016267750671514224,0.8468399402666433
Interleukin-9 signaling ,0.0165149809248807,0.971149731002942
CD22 mediated BCR regulation ,0.01661387302622729,1.0
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression ,0.016821546439055132,0.9659015322966604
Interleukin receptor SHC signaling ,0.016959995380940358,1.0
Interleukin-21 signaling ,0.0176522400903665,0.9808029997964636
Signal regulatory protein family interactions ,0.017699438593281915,1.0
HDMs demethylate histones ,0.017998362445079567,0.9219028677744274
Interleukin-7 signaling ,0.0206770484945981,1.0
Complement cascade ,0.022151830701636392,0.9756556884744748
Protein localization ,0.02386758692095953,0.181719480237476
FCERI mediated Ca+2 mobilization ,0.02533615636499662,1.0
Nef and signal transduction ,0.025420764051704254,1.0
PKMTs methylate histone lysines ,0.02555980465573429,0.9607900389651246
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function ,0.025773753913455287,1.0
Triglyceride catabolism ,0.025885002688492247,0.4383306126425393
rRNA modification in the nucleus and cytosol ,0.028426134212944324,0.9708115346178834
Glycoprotein hormones ,0.03138292137825773,1.0
HCMV Early Events ,0.03312032876995742,0.8200247483485188
Creation of C4 and C2 activators ,0.035339092416204296,1.0
Phosphorylation of CD3 and TCR zeta chains ,0.03654382151535075,1.0
Transcriptional regulation of granulopoiesis ,0.03803019372409841,0.8290831013442993
"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) ",0.038900877549361834,1.0
Interferon alpha/beta signaling ,0.03911182608257675,0.9808960906001868
Formation of the beta-catenin:TCF transactivating complex ,0.049933239701988284,0.8592176172451401
Pre-NOTCH Transcription and Translation ,0.050256965904337564,0.985106244981442
Lysosphingolipid and LPA receptors ,0.05101311012540303,0.7827311370089266
Signaling by the B Cell Receptor (BCR) ,0.051024203790618186,1.0
Role of phospholipids in phagocytosis ,0.05116062588988573,1.0
Role of LAT2/NTAL/LAB on calcium mobilization ,0.05139916967489068,1.0
Generation of second messenger molecules ,0.052411577562426405,0.973448399857236
Condensation of Prophase Chromosomes ,0.05781931725438552,0.8183999486751781
SIRT1 negatively regulates rRNA expression ,0.058927330889899925,0.9633608653671161
Regulation of TP53 Degradation ,0.059355959154748075,0.98653144469597
Classical antibody-mediated complement activation ,0.0594341529093012,1.0
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway ,0.06096368407679514,1.0
"Incretin synthesis, secretion, and inactivation ",0.068485433859872,1.0
Zinc influx into cells by the SLC39 gene family ,0.06864185043638367,0.9638268861929976
GAB1 signalosome ,0.07315973162772099,1.0
CD28 co-stimulation ,0.07504963652938046,1.0
Interleukin-27 signaling ,0.07805059098779696,0.8244848760320692
Regulation of signaling by CBL ,0.07864041173511413,1.0
TP53 Regulates Metabolic Genes ,0.0798303860863292,0.8311723884175812
NOTCH2 intracellular domain regulates transcription ,0.08161565124134157,1.0
Abacavir transport and metabolism ,0.08625165205080047,0.7542746851910109
Interleukin-6 signaling ,0.0942878014515424,0.4743738061287632
Transcriptional regulation by small RNAs ,0.09538998971909587,0.9379851950036296
RA biosynthesis pathway ,0.09583067632620346,1.0
GPVI-mediated activation cascade ,0.09917316310831292,1.0
Other interleukin signaling ,0.0994792731983364,0.9865233747487696
Regulation of TP53 Expression and Degradation ,0.10045239894561502,0.9767118928742976
Striated Muscle Contraction ,0.10085376102966613,1.0
Interleukin-20 family signaling ,0.10191670693683297,0.9357720508866016
IRS activation ,0.1022669261758554,1.0
Citric acid cycle (TCA cycle) ,0.1061689079509498,0.48648874061718106
Phase 1 - inactivation of fast Na+ channels ,0.10776888332893952,0.9778019465373688
Translocation of ZAP-70 to Immunological synapse ,0.1081037460681176,1.0
Scavenging of heme from plasma ,0.10820444089006168,1.0
CD209 (DC-SIGN) signaling ,0.10864780714443224,0.8775288480507311
VEGFA-VEGFR2 Pathway ,0.10901094229285152,1.0
CD28 dependent Vav1 pathway ,0.10961471669017904,1.0
Vasopressin-like receptors ,0.11024593760291776,1.0
Meiotic synapsis ,0.11461974900305845,1.0
The role of Nef in HIV-1 replication and disease pathogenesis ,0.1155262023026392,1.0
Regulation of Complement cascade ,0.11799359821795932,0.9136329157500648
RMTs methylate histone arginines ,0.11901169936555495,0.9656126434531516
Synthesis of IP3 and IP4 in the cytosol ,0.12006119179109564,1.0
HCMV Late Events ,0.12048067703620985,0.9672260028677988
Elevation of cytosolic Ca2+ levels ,0.12209975065966308,1.0
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant ,0.12262688301293274,1.0
Interleukin-2 signaling ,0.1234814887084461,1.0
DNA Double Strand Break Response ,0.12348261126743433,0.9692625268750912
Activation of C3 and C5 ,0.12351918658491745,0.9689867311441552
Regulation of PTEN mRNA translation ,0.12560247756606932,0.9714271585119868
STAT5 Activation ,0.12593158027237633,1.0
Cleavage of the damaged purine ,0.1264485155080046,1.0
Oxidative Stress Induced Senescence ,0.12723367857342086,0.9644018648958664
HCMV Infection ,0.1272648632985614,0.8867820192976277
Signaling by cytosolic FGFR1 fusion mutants ,0.12888570941797006,1.0
Fcgamma receptor (FCGR) dependent phagocytosis ,0.13135968883688748,1.0
Collagen biosynthesis and modifying enzymes ,0.13145223167896702,1.0
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) ",0.13181593350574675,0.9560766450674708
Dectin-2 family ,0.1325310938204991,0.9226219347374112
Amyloid fiber formation ,0.13414713547665072,0.8381007657351651
Pre-NOTCH Expression and Processing ,0.1350854470029569,1.0
Estrogen-dependent gene expression ,0.1365814910411941,1.0
Meiotic recombination ,0.13857480455966853,0.8462879441634948
Reproduction ,0.1388296764754118,0.8296436429194118
DNA Damage/Telomere Stress Induced Senescence ,0.13888451159003487,0.8785679784730718
Recognition and association of DNA glycosylase with site containing an affected purine ,0.13901566969679058,1.0
Surfactant metabolism ,0.13933305876954885,1.0
B-WICH complex positively regulates rRNA expression ,0.13942763268131267,0.95725263124416
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks ,0.13947303586257434,0.9718789620165766
Depurination ,0.1408826146918037,1.0
Activation of HOX genes during differentiation ,0.14097228550345814,0.8796042473031971
tRNA modification in the nucleus and cytosol ,0.14162172230685574,0.959749614510766
HDR through MMEJ (alt-NHEJ) ,0.1423437292240513,1.0
Chromatin modifying enzymes ,0.1432317235139898,0.8269319874824461
Packaging Of Telomere Ends ,0.1433264415980718,0.9799528111942712
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant ,0.14384697775766742,1.0
EPH-ephrin mediated repulsion of cells ,0.14922373078744525,0.9611927442322336
Activated NTRK2 signals through PI3K ,0.14957626154615153,1.0
Beta defensins ,0.1515516698708558,0.9026432283313016
HATs acetylate histones ,0.15157134766342678,0.9439406021726428
FCERI mediated MAPK activation ,0.1523447364200315,1.0
Competing endogenous RNAs (ceRNAs) regulate PTEN translation ,0.15702087851811722,1.0
CD28 dependent PI3K/Akt signaling ,0.15908567095868584,1.0
Folding of actin by CCT/TriC ,0.1606599395856099,0.8360786987673029
PD-1 signaling ,0.16188047266896807,1.0
"Base-Excision Repair, AP Site Formation ",0.16191796043674409,0.986901890204098
Signaling by VEGF ,0.16229580168844931,0.9828149575425056
Collagen formation ,0.1708370262247445,1.0
Recognition and association of DNA glycosylase with site containing an affected pyrimidine ,0.17184974911503856,0.9808209792630772
tRNA Aminoacylation ,0.18253716718552213,0.8292358580694098
RUNX2 regulates osteoblast differentiation ,0.1847397950016252,0.8972229169350785
Signaling by Erythropoietin ,0.18550287280973374,1.0
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation ",0.18873248504180187,0.8584065133272807
RUNX2 regulates genes involved in differentiation of myeloid cells ,0.1892851027185126,1.0
Activation of anterior HOX genes in hindbrain development during early embryogenesis ,0.19349464840335626,0.8977542348508815
Regulation of RUNX1 Expression and Activity ,0.201015111741124,1.0
Transcriptional regulation by RUNX2 ,0.2117816737989328,1.0
Collagen chain trimerization ,0.21192606325486865,1.0
MET promotes cell motility ,0.212189166217463,1.0
Triglyceride metabolism ,0.21230717635341675,0.24640497117561336
Zinc transporters ,0.2125350978905038,0.9599177679858096
Class I peroxisomal membrane protein import ,0.21336365710317148,0.5060948226085841
Axon guidance ,0.21461144821813968,0.6887549208198929
Nef Mediated CD4 Down-regulation ,0.21585393943749434,1.0
Formation of TC-NER Pre-Incision Complex ,0.21758742637930076,1.0
Positive epigenetic regulation of rRNA expression ,0.219802614309812,0.9689107762839962
Signaling by Retinoic Acid ,0.2241764969921862,0.9119668557741952
"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) ",0.2253345278503797,1.0
Ephrin signaling ,0.2264130766940385,1.0
Meiosis ,0.2278803655363279,0.836641657566146
Regulation of actin dynamics for phagocytic cup formation ,0.22959541828594804,1.0
Defensins ,0.23007131489103136,0.96342854249207
DAP12 interactions ,0.2305844796623965,1.0
Cholesterol biosynthesis via lathosterol ,0.23097995424225976,1.0
RHO GTPases activate PKNs ,0.23159579249781745,0.7877558221594919
Chromatin organization ,0.23223965800381746,0.8361730929620836
Depyrimidination ,0.23259422236718205,0.99624330126919
LDL clearance ,0.2328054156683629,0.9641277988066976
Chemokine receptors bind chemokines ,0.23352009966603954,0.9781090371869312
APC truncation mutants have impaired AXIN binding ,0.23368365666398386,1.0
Senescence-Associated Secretory Phenotype (SASP) ,0.2341303190984293,0.972858564788588
Organic cation transport ,0.2368315459225325,0.90460711561629
Regulation of gene expression in early pancreatic precursor cells ,0.2436674955626208,0.9824223763485452
ESR-mediated signaling ,0.24406310369966694,1.0
Signaling by MST1 ,0.245101825639768,0.8308884129279331
Sulfur amino acid metabolism ,0.2538855099527876,0.9653481974043226
Butyrophilin (BTN) family interactions ,0.25488036920646834,0.9648174649765572
Deposition of new CENPA-containing nucleosomes at the centromere ,0.2610454799245963,1.0
Interferon Signaling ,0.2612485723062588,0.8157216812827257
Utilization of Ketone Bodies ,0.2617063967712601,1.0
Interleukin-23 signaling ,0.2646331133751874,1.0
TCR signaling ,0.2648134824220914,0.8628621564401381
Transcriptional regulation of pluripotent stem cells ,0.2711758184595601,0.6777855949057939
BBSome-mediated cargo-targeting to cilium ,0.2717506172764732,0.7260086801371205
ADP signalling through P2Y purinoceptor 1 ,0.2728725412409327,1.0
AXIN missense mutants destabilize the destruction complex ,0.2730831209610101,1.0
Mitotic Prophase ,0.2735988294384695,0.8458481885087391
S45 mutants of beta-catenin aren't phosphorylated ,0.2742659116981576,1.0
Collagen degradation ,0.2750086064888901,0.908972341230259
Truncations of AMER1 destabilize the destruction complex ,0.2754378324290948,1.0
Synthesis of PIPs at the Golgi membrane ,0.2763905367166687,0.8136483460421795
Protein repair ,0.2779828697189261,1.0
RNA Polymerase I Promoter Clearance ,0.27889823227562416,1.0
Peptide hormone biosynthesis ,0.2800060527390934,0.9709664680759312
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins ,0.2851541391003679,1.0
Nef Mediated CD8 Down-regulation ,0.2873310004625202,1.0
TCF dependent signaling in response to WNT ,0.2878766003778262,1.0
mRNA Splicing - Major Pathway ,0.2903647153592733,1.0
Disassembly of the destruction complex and recruitment of AXIN to the membrane ,0.2923003285551864,1.0
Interleukin-10 signaling ,0.2923648023271428,0.9578070449397232
Cdc20:Phospho-APC/C mediated degradation of Cyclin A ,0.2928252822470821,1.0
VEGFR2 mediated cell proliferation ,0.29303554818784866,1.0
PTK6 Activates STAT3 ,0.29304876195855944,0.8404318723425225
RORA activates gene expression ,0.2932293938231004,1.0
Interaction With Cumulus Cells And The Zona Pellucida ,0.2935140954612411,1.0
Negative epigenetic regulation of rRNA expression ,0.2939060153729116,0.8235597953815516
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex ,0.2953919827493815,1.0
Integrin signaling ,0.2957083025092843,1.0
Estrogen-stimulated signaling through PRKCZ ,0.2974627761287841,1.0
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 ",0.2985371028834655,1.0
Regulation of TP53 Activity ,0.29996903308301703,0.8158823776666232
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer ,0.30234652990073324,1.0
YAP1- and WWTR1 (TAZ)-stimulated gene expression ,0.3039610769535334,0.8943560889336598
Cellular Senescence ,0.30532965899173553,0.8322627135216943
Interleukin-18 signaling ,0.3054800840018208,0.9787130556748308
NOSIP mediated eNOS trafficking ,0.3062553525838451,1.0
Signaling by NOTCH ,0.3062613003626678,1.0
Cleavage of the damaged pyrimidine  ,0.306473071557956,0.9793029656254092
DSCAM interactions ,0.3069528415713729,1.0
Cytokine Signaling in Immune system ,0.3079299824930118,1.0
Interferon gamma signaling ,0.30904247045404265,0.8454380529888479
Cholesterol biosynthesis via desmosterol ,0.30950137343315903,1.0
Adaptive Immune System ,0.3100649066027843,1.0
Activation of gene expression by SREBF (SREBP) ,0.31051476146430285,0.8470553205909592
RNA Polymerase I Promoter Escape ,0.3134842240671891,0.9729263768798432
Nucleosome assembly ,0.3158976702468817,1.0
Wax and plasmalogen biosynthesis ,0.3262849312043925,0.9653853556464708
APC-Cdc20 mediated degradation of Nek2A ,0.3300457251997904,1.0
Activation of Ca-permeable Kainate Receptor ,0.3344914500693484,1.0
T41 mutants of beta-catenin aren't phosphorylated ,0.3347772330863624,1.0
activated TAK1 mediates p38 MAPK activation ,0.33608296535003473,0.9643703295679398
Pre-NOTCH Processing in the Endoplasmic Reticulum ,0.33645755357761903,1.0
"AXIN mutants destabilize the destruction complex, activating WNT signaling ",0.3364898052641208,1.0
DAP12 signaling ,0.33680296403937715,1.0
Inositol phosphate metabolism ,0.3368203164301549,1.0
Regulation of IFNA signaling ,0.33734017247975306,0.968434909649635
Regulation of TP53 Activity through Acetylation ,0.3374260305509027,1.0
Class C/3 (Metabotropic glutamate/pheromone receptors) ,0.3376496438090134,0.8573135667470005
Misspliced GSK3beta mutants stabilize beta-catenin ,0.33811129698704834,1.0
Activation of AKT2 ,0.3382050530792605,0.9914363237710924
Gene Silencing by RNA ,0.3385417077311561,0.9761813448121176
Presynaptic nicotinic acetylcholine receptors ,0.33855817806385263,1.0
Fc epsilon receptor (FCERI) signaling ,0.3386598842590978,1.0
Activation of the TFAP2 (AP-2) family of transcription factors ,0.3391923005340882,0.8678105738521941
Telomere Maintenance ,0.3392527059441024,0.9664117709612242
NoRC negatively regulates rRNA expression ,0.33948769474519785,0.8798846687520732
truncated APC mutants destabilize the destruction complex ,0.339976292569158,1.0
Processing of DNA double-strand break ends ,0.3400334267587285,0.8333621607750048
RNA Polymerase I Transcription ,0.3401667298386761,1.0
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling ,0.34067400231730605,0.9795934593292059
NRAGE signals death through JNK ,0.3408085899265077,1.0
Interleukin-4 and Interleukin-13 signaling ,0.34169775727865315,1.0
S33 mutants of beta-catenin aren't phosphorylated ,0.3429915206863458,1.0
TNFs bind their physiological receptors ,0.3462562814533344,1.0
Beta-catenin phosphorylation cascade ,0.3474933369180784,1.0
Sema4D mediated inhibition of cell attachment and migration ,0.3486191402426978,1.0
Regulation of TNFR1 signaling ,0.34884043320449176,1.0
mRNA Splicing ,0.34897587176351863,1.0
S37 mutants of beta-catenin aren't phosphorylated ,0.34941051708284265,1.0
Phase 4 - resting membrane potential ,0.34950003148492365,1.0
Regulation of cortical dendrite branching ,0.3498206720731777,0.9778920366076329
Nephrin family interactions ,0.3509267396366977,0.687201757432697
Regulation of TP53 Activity through Association with Co-factors ,0.3528792650289889,0.9734024754298586
Neddylation ,0.3547732538235666,0.8915063252010708
Downstream signal transduction ,0.3576255407218579,1.0
Activation of RAS in B cells ,0.3586759462705464,0.8423854916422563
AMER1 mutants destabilize the destruction complex ,0.3594777329999257,1.0
Resolution of D-loop Structures through Holliday Junction Intermediates ,0.3637286638748475,0.8805783044774915
Phosphate bond hydrolysis by NUDT proteins ,0.3650886517772445,0.8961858023523336
AKT phosphorylates targets in the nucleus ,0.3707411235183439,1.0
Metabolism of nucleotides ,0.3716800865048314,0.8253570979195046
Peptide hormone metabolism ,0.37268815744402783,0.950709611489428
Inactivation of APC/C via direct inhibition of the APC/C complex ,0.37291042204528935,1.0
RNA Polymerase III Chain Elongation ,0.3747804861116132,1.0
Acyl chain remodeling of CL ,0.3769778667199021,1.0
TRAIL  signaling ,0.3794028704288199,0.8426122428756637
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint ,0.3795911146409086,1.0
Methylation ,0.3802832203762812,0.8261900414335136
RAF activation ,0.3803055260672426,1.0
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters ,0.3811480141080604,1.0
Negative feedback regulation of MAPK pathway ,0.381502852420304,1.0
Ionotropic activity of kainate receptors ,0.3815145842231654,1.0
Phase II - Conjugation of compounds ,0.3815563257458138,0.664749241584104
ECM proteoglycans ,0.3818892142161296,0.9801484004798596
Homology Directed Repair ,0.382317093787552,0.8356777501064409
Sensing of DNA Double Strand Breaks ,0.3831858950800831,0.8313562387407156
Signaling by Interleukins ,0.3836385249860736,1.0
Assembly of collagen fibrils and other multimeric structures ,0.38778036320195053,1.0
Highly sodium permeable acetylcholine nicotinic receptors ,0.3884955973471007,1.0
RHO GTPases activate CIT ,0.3890257529965417,0.9989111262375948
Epigenetic regulation of gene expression ,0.3919107400632553,0.8284442440273738
DNA Damage Recognition in GG-NER ,0.3930185468062963,0.96444735807727
Organic cation/anion/zwitterion transport ,0.3960225792970619,1.0
Interleukin-17 signaling ,0.3974934604132528,0.9189808074776318
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) ,0.4003859584938918,0.8281463763115139
G2/M DNA damage checkpoint ,0.40266685428214094,0.8335651286980785
MECP2 regulates transcription of neuronal ligands ,0.4030756344399216,0.9038385894490726
Pyrimidine salvage ,0.40369905597968603,1.0
Signaling by FGFR3 fusions in cancer ,0.40392478795015097,1.0
DNA Double-Strand Break Repair ,0.40424640606736223,0.892359213239787
Digestion of dietary carbohydrate ,0.4053395063956158,0.8286713286713288
Lactose synthesis ,0.4053502655425877,1.0
NTF3 activates NTRK2 (TRKB) signaling ,0.40708484009772616,0.9676083345808116
Synthesis of dolichyl-phosphate mannose ,0.4080034042683583,0.8690079728445034
Growth hormone receptor signaling ,0.4092777491945928,1.0
Signaling by EGFR ,0.4175034341735098,1.0
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) ,0.4177169302181668,1.0
Factors involved in megakaryocyte development and platelet production ,0.4187426870414079,0.7505292872265349
G1/S-Specific Transcription ,0.4204723822276034,1.0
Signaling by WNT in cancer ,0.4204858626510831,1.0
MAPK3 (ERK1) activation ,0.4255640070631618,0.971023065087132
Intestinal absorption ,0.42558712343884586,0.9985147297520788
Signaling by NTRK2 (TRKB) ,0.4257304962970743,1.0
Autodegradation of Cdh1 by Cdh1:APC/C ,0.4277527844305752,1.0
Abacavir metabolism ,0.4279315103465503,0.4872723606668561
Signaling by SCF-KIT ,0.4280711487208215,0.9656305864256934
RNA Polymerase I Transcription Termination ,0.4301854631750112,1.0
Cargo trafficking to the periciliary membrane ,0.4302373125566191,0.6447527343019964
APC/C:Cdc20 mediated degradation of mitotic proteins ,0.4305040328865413,1.0
PI3K Cascade ,0.4314609037464733,0.967118908008468
Interconversion of polyamines ,0.43365126324088,1.0
GP1b-IX-V activation signalling ,0.4345373873225513,1.0
Cellular responses to stress ,0.4357478600533264,0.2368854387203011
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate ,0.4364042370899871,0.8340452566006381
Lectin pathway of complement activation ,0.4370047988512037,1.0
MAPK1 (ERK2) activation ,0.4376674619319533,0.9879294747082018
Synthesis of GDP-mannose ,0.43795779825642783,0.8354146850357461
Global Genome Nucleotide Excision Repair (GG-NER) ,0.4390060358750228,0.8280816984642501
Transcriptional regulation by RUNX1 ,0.44452159058681934,0.8320853188109826
Advanced glycosylation endproduct receptor signaling ,0.4463041608893264,1.0
Processing of Capped Intron-Containing Pre-mRNA ,0.4473858590916015,1.0
MTF1 activates gene expression ,0.4492100523513901,0.9648187451992536
Post-transcriptional silencing by small RNAs ,0.4493001776083787,1.0
Digestion and absorption ,0.4595870542768163,0.8701787287746602
Regulation of APC/C activators between G1/S and early anaphase ,0.4644991902015673,1.0
RNA Polymerase III Transcription Termination ,0.467942166730692,1.0
Defective DPM3 causes DPM3-CDG (CDG-1o) ,0.4686862092435805,0.8559245472744818
Galactose catabolism ,0.4707932640097647,1.0
Alpha-oxidation of phytanate ,0.47100191693037,0.6716728930913828
Organelle biogenesis and maintenance ,0.4719253103879437,0.3017899531661
VLDL assembly ,0.4722394906481632,1.0
The NLRP3 inflammasome ,0.4727866545211605,0.9647358035348026
Formation of Incision Complex in GG-NER ,0.4738575951477504,0.826709987260446
G beta:gamma signalling through CDC42 ,0.4779783695825535,1.0
Regulation of PAK-2p34 activity by PS-GAP/RHG10 ,0.4783192912304866,0.9765391657362776
ALKBH3 mediated reversal of alkylation damage ,0.4825053367067402,0.99875402241409
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) ,0.4829604964090544,0.8241172744881509
Ovarian tumor domain proteases ,0.483093367304217,0.9645714783661464
Base Excision Repair ,0.4838709396461812,1.0
Response of EIF2AK1 (HRI) to heme deficiency ,0.4845448750445011,1.0
HDR through Single Strand Annealing (SSA) ,0.4847410168262827,0.8355550946477174
Hyaluronan metabolism ,0.4852431811692096,0.8422060785162849
Plasma lipoprotein clearance ,0.4859120234205753,0.8328806277556674
Eicosanoid ligand-binding receptors ,0.4860201808738391,1.0
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 ",0.4863923721691159,1.0
Erythropoietin activates RAS ,0.4876485202500092,1.0
Fanconi Anemia Pathway ,0.4876577711297975,1.0
"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases ",0.4878504184588053,0.7906975069491452
G2 Phase ,0.4885038085177113,0.8386535956925075
IRS-related events triggered by IGF1R ,0.4891939529356861,0.9817258553363336
Extracellular matrix organization ,0.4892158117248513,1.0
MET activates PI3K/AKT signaling ,0.4892264478184257,1.0
Constitutive Signaling by AKT1 E17K in Cancer ,0.48936811495655,1.0
Intestinal saccharidase deficiencies ,0.4920256523111973,0.9531701661821832
APC/C:Cdc20 mediated degradation of Cyclin B ,0.4944519485217666,1.0
Trafficking of myristoylated proteins to the cilium ,0.4971610154598386,0.9352159249830388
Downregulation of SMAD2/3:SMAD4 transcriptional activity ,0.4972827351636924,1.0
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding ,0.4995228605100483,1.0
Platelet Aggregation (Plug Formation) ,0.50004574493857,1.0
Synthesis of very long-chain fatty acyl-CoAs ,0.5012065662791783,0.6684473954089181
Cell surface interactions at the vascular wall ,0.5018586033364106,1.0
Assembly of Viral Components at the Budding Site ,0.5072291906705417,0.9811305915263028
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding ,0.5073629328600555,0.8438257779595438
Rab regulation of trafficking ,0.5074611096062313,1.0
PTK6 Down-Regulation ,0.5083532519382584,0.9410360877059316
TNFR1-induced NFkappaB signaling pathway ,0.5087587749616441,0.966460736235453
Infectious disease ,0.5098950983301739,1.0
RUNX1 regulates transcription of genes involved in interleukin signaling ,0.5106519176827118,0.8392714704207878
Transcription-Coupled Nucleotide Excision Repair (TC-NER) ,0.5106867195569077,1.0
CREB1 phosphorylation through the activation of Adenylate Cyclase ,0.5108618669456504,0.9763833519751114
PKA-mediated phosphorylation of CREB ,0.5116932472332678,0.9581227552232968
Resolution of AP sites via the single-nucleotide replacement pathway ,0.5118724355855429,0.9067715719750634
Defective DPM1 causes DPM1-CDG (CDG-1e) ,0.5122784301204962,0.9109652480214904
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components ,0.5124506572897602,1.0
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex ,0.5128756771539711,0.8250331819973188
Cellular responses to external stimuli ,0.5150472728106165,0.5961870431680544
SOS-mediated signalling ,0.5153057424157218,1.0
Mitochondrial biogenesis ,0.5161866734719104,0.8821563132447202
MASTL Facilitates Mitotic Progression ,0.518515712062466,0.9081896441456688
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha ,0.5196418435835222,1.0
Virus Assembly and Release ,0.5197868087089794,0.9838916232384196
Immune System ,0.5211509644016561,0.08228010521588502
IRF3-mediated induction of type I IFN ,0.521349526091441,0.8688773150090752
Activation of RAC1 ,0.5322316237540465,0.914751609247022
NTF3 activates NTRK3 signaling ,0.5325784671969986,0.9637535603973708
PAOs oxidise polyamines to amines ,0.5326751179721727,1.0
GRB7 events in ERBB2 signaling ,0.5331272758810279,0.9832784631113386
FGFR1 mutant receptor activation ,0.5332777311709609,1.0
Loss of MECP2 binding ability to 5mC-DNA ,0.5337568510046299,1.0
"TET1,2,3 and TDG demethylate DNA ",0.5362860191123076,0.9994923254093326
Role of second messengers in netrin-1 signaling ,0.5379202647339321,0.8271846361119473
RUNX2 regulates genes involved in cell migration ,0.5405282634897369,1.0
Attachment of GPI anchor to uPAR ,0.5407549621166962,0.8676496370437821
Synthesis of PA ,0.5438132203320838,1.0
SLIT2:ROBO1 increases RHOA activity ,0.5466842020466505,1.0
GLI proteins bind promoters of Hh responsive genes to promote transcription ,0.5466850006853935,1.0
RNA Polymerase II Transcription Initiation And Promoter Clearance ,0.5475598113815754,1.0
Adrenoceptors ,0.5475880099504074,1.0
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 ",0.5477706307977366,0.9641878896571262
Adenylate cyclase activating pathway ,0.5526090623247506,0.8301343427214988
Keratinization ,0.5527238300811628,1.0
Resolution of D-Loop Structures ,0.5530392095561146,0.8244263381878061
Tryptophan catabolism ,0.554338180761215,1.0
Olfactory Signaling Pathway ,0.5546569668912806,1.0
Intracellular oxygen transport ,0.554703697071408,0.9991288254852262
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways ",0.5549864284411227,0.8475371897200105
SUMOylation of chromatin organization proteins ,0.5557221656969391,0.9657684295172476
RUNX1 regulates transcription of genes involved in differentiation of HSCs ,0.5559920921173281,0.956021323089866
Integrin cell surface interactions ,0.5562182150564987,1.0
tRNA processing ,0.5562601641447288,0.8318814545380162
Purine catabolism ,0.5569776142355352,1.0
Synthesis of glycosylphosphatidylinositol (GPI) ,0.5584442546685213,0.8261983106814691
Degradation of the extracellular matrix ,0.5613178316231683,1.0
Syndecan interactions ,0.5616083521514866,0.9961575741392256
Glycogen storage disease type IV (GBE1) ,0.5616508829096368,0.9561661010424809
Metabolism of steroid hormones ,0.5618773600234108,0.8874922796789253
Neurotransmitter clearance ,0.5632581593981314,0.8697489381554582
APC/C-mediated degradation of cell cycle proteins ,0.5641459674039601,1.0
IRS-mediated signalling ,0.5643490610581214,0.9655145074014032
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription ,0.5654097146708363,1.0
Signaling by NOTCH2 ,0.5656274563877786,1.0
TNFR2 non-canonical NF-kB pathway ,0.5670967551720263,1.0
Signal amplification ,0.5673285520183593,1.0
Stimulation of the cell death response by PAK-2p34 ,0.5673320175914718,0.9806473052871824
Signaling by WNT ,0.5674929678256297,1.0
Pervasive developmental disorders ,0.5681432047636793,1.0
Rhesus blood group biosynthesis ,0.5684183132536579,1.0
Cytochrome P450 - arranged by substrate type ,0.5687832015411066,0.9559833624964956
Metal ion SLC transporters ,0.5688713312511818,0.967523358270729
FLT3 Signaling ,0.5689488494151371,1.0
CHL1 interactions ,0.5691251272763119,0.9874939146121012
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation ",0.5692083923948975,0.8179455951518444
C-type lectin receptors (CLRs) ,0.569423475563053,1.0
MET activates RAP1 and RAC1 ,0.5694258072502034,0.9963015134933764
GDP-fucose biosynthesis ,0.5696433894331834,1.0
Negative regulation of NOTCH4 signaling ,0.5698189037629522,1.0
Mitotic Spindle Checkpoint ,0.571047448442276,0.979710738064412
G-protein mediated events ,0.5711152835612616,0.9637406957290432
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes ,0.5714766193806345,0.9729041161259976
Separation of Sister Chromatids ,0.5723448813062405,0.9622878395814176
RNA Polymerase III Transcription Initiation From Type 3 Promoter ,0.5727227972465749,1.0
Mitotic Metaphase and Anaphase ,0.5728571483850636,0.8610377253400667
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening ,0.5732070294655712,1.0
Transport and synthesis of PAPS ,0.5736175505928373,0.9758249186203852
NADE modulates death signalling ,0.573809990729404,0.8837818563610845
Defective DHDDS causes retinitis pigmentosa 59 ,0.5740552470508905,1.0
Interactions of Tat with host cellular proteins ,0.5745794353498596,0.8912535090016541
RSK activation ,0.5746564208064691,1.0
Activation of the AP-1 family of transcription factors ,0.5750671495027447,0.7256663138367433
RUNX2 regulates bone development ,0.5754020339201719,0.9304611377628224
Phase 3 - rapid repolarisation ,0.576236047233037,1.0
Mitochondrial tRNA aminoacylation ,0.5767817967815545,0.8323786305437681
Vif-mediated degradation of APOBEC3G ,0.5775292549642747,1.0
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components ,0.5793583180673031,1.0
Transcriptional regulation by RUNX3 ,0.5800206761843624,1.0
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) ,0.5818996286735936,1.0
PKA activation in glucagon signalling ,0.5824630310863578,0.8696885959182854
Sema3A PAK dependent Axon repulsion ,0.5825750425914058,0.9809576522380264
Nucleotide Excision Repair ,0.5826030496176516,0.8277665399899615
Scavenging by Class F Receptors ,0.5830704319632204,0.8264862937361338
Signaling by high-kinase activity BRAF mutants ,0.5839718323355059,1.0
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) ,0.586661610584181,0.9147021829634764
p38MAPK events ,0.5876777692638585,1.0
"Cell death signalling via NRAGE, NRIF and NADE ",0.5877314911370956,1.0
Prostanoid ligand receptors ,0.5894590718141434,1.0
SUMO is conjugated to E1 (UBA2:SAE1) ,0.5923680191974081,0.9800842281594668
HIV Transcription Initiation ,0.5930224488275091,1.0
TNF signaling ,0.5946684389762286,1.0
Asymmetric localization of PCP proteins ,0.595241968788366,1.0
G beta:gamma signalling through BTK ,0.5955431727982803,1.0
Caspase-mediated cleavage of cytoskeletal proteins ,0.5957406941035935,1.0
Regulation of ornithine decarboxylase (ODC) ,0.5967491490284111,1.0
RNA Polymerase II Transcription Initiation ,0.5973805977945895,1.0
Degradation of GLI2 by the proteasome ,0.5976989706712452,1.0
Defective B3GALTL causes Peters-plus syndrome (PpS) ,0.5978330935177102,1.0
Serotonin Neurotransmitter Release Cycle ,0.5980406601498562,1.0
Uptake and function of anthrax toxins ,0.5981761882671864,0.9772698870319284
Cyclin E associated events during G1/S transition  ,0.5984741644743946,1.0
Phosphorylation of the APC/C ,0.598561512316468,1.0
Defective DPM2 causes DPM2-CDG (CDG-1u) ,0.5989224822135545,0.8615799309706743
Mitotic G2-G2/M phases ,0.5995716986921121,0.8324758433870396
Adrenaline signalling through Alpha-2 adrenergic receptor ,0.6006825305552798,1.0
Conjugation of salicylate with glycine ,0.6018449277783119,0.8300396434257986
IGF1R signaling cascade ,0.6018565973448993,0.9870441444878246
Pregnenolone biosynthesis ,0.6028774465324053,1.0
Regulation of gene expression by Hypoxia-inducible Factor ,0.6029246005241291,0.6664922938740864
NOSTRIN mediated eNOS trafficking ,0.6032632843140484,0.8388723375248603
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) ,0.6036899230484319,0.9713434175282464
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation ",0.6038150972017129,0.9946949751025262
SUMOylation of ubiquitinylation proteins ,0.6038899623919497,0.9627048496536508
Metabolism of lipids ,0.6044855593697366,0.2386123051260666
Beta-oxidation of pristanoyl-CoA ,0.6051732782041006,0.9562435703771434
Signaling by NTRKs ,0.6057821785142462,1.0
RNA Polymerase II Promoter Escape ,0.6058476428447563,1.0
Hemostasis ,0.6062817614095994,0.3524331173413742
Antimicrobial peptides ,0.606743612879837,1.0
Insulin receptor signalling cascade ,0.6068020755419108,0.9700072368717808
TBC/RABGAPs ,0.6069284822296599,1.0
Synthesis of dolichyl-phosphate-glucose ,0.6069599617306844,0.980224579524096
Activation of BMF and translocation to mitochondria ,0.6071505775457585,0.6879845379265609
Neurophilin interactions with VEGF and VEGFR ,0.6073313476121328,0.9977816678734108
Processing and activation of SUMO ,0.6074067078120443,0.9735370013443304
Triglyceride biosynthesis ,0.6075665521211389,0.8205687315889593
Transcriptional Regulation by MECP2 ,0.6078784034717523,0.9250520566989792
"BMAL1:CLOCK,NPAS2 activates circadian gene expression ",0.6080760124979291,1.0
Serotonin and melatonin biosynthesis ,0.6085221133770018,1.0
Neurexins and neuroligins ,0.6086954267443481,1.0
vRNP Assembly ,0.6092474108263339,1.0
G alpha (s) signalling events ,0.6093560630465765,1.0
GPCR ligand binding ,0.6097592376586036,1.0
DEx/H-box helicases activate type I IFN and inflammatory cytokines production  ,0.6102730753676517,0.8298100981587221
COPII-mediated vesicle transport ,0.6107602203402657,1.0
GPCR downstream signalling ,0.6111834594141814,1.0
RUNX3 regulates CDKN1A transcription ,0.6118411613166765,1.0
Signaling by Nuclear Receptors ,0.6141883497324282,1.0
Xenobiotics ,0.6159610634977594,0.9666869375617276
Signaling by TGF-beta Receptor Complex ,0.6160055554870446,0.938132826306304
Innate Immune System ,0.6165411712651341,0.20326233399627894
ER to Golgi Anterograde Transport ,0.6167555197419854,1.0
APC/C:Cdc20 mediated degradation of Securin ,0.6194151418978803,1.0
Formation of the cornified envelope ,0.6199165166561923,1.0
Death Receptor Signalling ,0.6199363450443997,0.82245645037423
GRB2 events in EGFR signaling ,0.6201626070536036,1.0
Manipulation of host energy metabolism ,0.6205674028989426,1.0
Lysine catabolism ,0.6210005873613889,1.0
Signaling by FGFR4 in disease ,0.6210669858439534,1.0
CTLA4 inhibitory signaling ,0.6213443752861727,1.0
MyD88 deficiency (TLR2/4) ,0.6217486552873316,0.9795342913966768
Homologous DNA Pairing and Strand Exchange ,0.6217529840557836,0.8224002400957773
Molybdenum cofactor biosynthesis ,0.6219126469484416,1.0
Aggrephagy ,0.6219354181559885,0.9572735463575612
Glycogen storage disease type II (GAA) ,0.6222154336587433,0.979337134713654
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC ",0.6226933451485166,0.9864673552746948
Nonhomologous End-Joining (NHEJ) ,0.6228481178560439,0.9607929607929608
Regulation of gene expression in beta cells ,0.6228962954652575,1.0
ROS and RNS production in phagocytes ,0.6229614629893269,0.8240387699809012
Signaling by NOTCH4 ,0.6231297808272903,1.0
Prevention of phagosomal-lysosomal fusion ,0.6232147610733753,0.8948972867042063
Muscle contraction ,0.6242712498666486,1.0
Hyaluronan uptake and degradation ,0.6259519397788983,0.8289152234106363
Activation of RAC1 downstream of NMDARs ,0.6261995685665063,0.9608983442195086
Mucopolysaccharidoses ,0.6266761558551802,0.7979678919557897
Activation and oligomerization of BAK protein ,0.6276727668794339,1.0
LDL remodeling ,0.6276995294477518,0.8385241988270075
Transport of Mature mRNA Derived from an Intronless Transcript ,0.6283123860271258,0.9872404520756618
Neurotransmitter receptors and postsynaptic signal transmission ,0.6287845069293219,0.7423493937255404
Signalling to RAS ,0.6290244749787532,1.0
Dopamine Neurotransmitter Release Cycle ,0.6296910198508933,0.967310114804822
Signaling by TGF-beta family members ,0.6303715569787403,1.0
Transport of glycerol from adipocytes to the liver by Aquaporins ,0.6304303902520775,0.8335856035411053
Regulation of mitotic cell cycle ,0.6321110847467463,1.0
ISG15 antiviral mechanism ,0.6322413607579404,0.9751202249298491
Loss of function of MECP2 in Rett syndrome ,0.6330542549094399,1.0
Signalling to STAT3 ,0.6349903032506836,0.8432933383785285
PIP3 activates AKT signaling ,0.6351249306065366,1.0
RNF mutants show enhanced WNT signaling and proliferation ,0.6354384760627719,1.0
Transport of Mature mRNAs Derived from Intronless Transcripts ,0.6357172332171749,0.9829681501189368
Defects in vitamin and cofactor metabolism ,0.6397942039163467,0.7760160328967669
Interleukin-6 family signaling ,0.6401089426797841,0.8795038228624188
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 ,0.6403497780326536,0.9593473520292379
TRAF3-dependent IRF activation pathway ,0.6403609684546482,0.9359276696706208
MAP kinase activation ,0.6408403737459523,0.9338627761998846
Type II Na+/Pi cotransporters ,0.6421665877908683,1.0
Classical Kir channels ,0.6424579634036902,0.9366967869172744
Biosynthesis of DPAn-3-derived maresins ,0.6424580576692955,0.9643026398847704
PI3K/AKT Signaling in Cancer ,0.6435920925684133,1.0
Adenylate cyclase inhibitory pathway ,0.6436425137794057,0.8237109834215404
IRAK2 mediated activation of TAK1 complex ,0.6438595458004557,0.9644237581497124
Transport of the SLBP independent Mature mRNA ,0.6444585638888348,0.9603587275605624
PKB-mediated events ,0.6449129036781825,0.9118900839496344
TRAF6 mediated IRF7 activation ,0.6456361295274047,0.8138281188739904
Molecules associated with elastic fibres ,0.6474963884427665,0.9796815140135094
Transport of the SLBP Dependant Mature mRNA ,0.6476889444808498,0.9577118615178384
Activation of kainate receptors upon glutamate binding ,0.648146219346381,1.0
FCERI mediated NF-kB activation ,0.6484376583578874,1.0
Fatty acyl-CoA biosynthesis ,0.6486341328350932,0.6783634306570087
Proton/oligopeptide cotransporters ,0.6487420740437718,1.0
Other semaphorin interactions ,0.6490117862424803,0.9813165001266652
p75 NTR receptor-mediated signalling ,0.649176477449541,0.8459456291758404
Antiviral mechanism by IFN-stimulated genes ,0.649477633963384,0.8344014698126508
Displacement of DNA glycosylase by APEX1 ,0.649604443883492,1.0
Regulation of MECP2 expression and activity ,0.6496959637874385,1.0
RNA Polymerase II HIV Promoter Escape ,0.6497118787614498,1.0
Signaling by Insulin receptor ,0.6501441705050117,0.8797625472207232
G2/M Transition ,0.6511650549653178,0.8190366029006072
Intestinal hexose absorption ,0.6516565320675329,1.0
Interleukin-12 family signaling ,0.6518834061907309,0.9217725807442859
RNA Polymerase III Transcription Initiation ,0.6521545680553384,1.0
HuR (ELAVL1) binds and stabilizes mRNA ,0.6522628467342317,1.0
Defective ST3GAL3 causes MCT12 and EIEE15 ,0.6524976712940945,1.0
Abacavir transmembrane transport ,0.6525432297768095,0.9649496774969782
Signal attenuation ,0.6528174172424063,1.0
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion ,0.6533116588050749,1.0
Prefoldin mediated transfer of substrate  to CCT/TriC ,0.654217884578913,0.950901357755012
AMPK inhibits chREBP transcriptional activation activity ,0.6544107525211217,0.5842278164084796
Signaling by Receptor Tyrosine Kinases ,0.65501660335874,0.6726154233510993
Chromosome Maintenance ,0.655623989304946,0.9651271512399564
Degradation of AXIN ,0.6556770856010166,1.0
CLEC7A/inflammasome pathway ,0.6579084036641819,0.6649344539252797
Negative regulation of MAPK pathway ,0.6583417410751439,1.0
TCF7L2 mutants don't bind CTBP ,0.6587366926038568,1.0
MAPK1/MAPK3 signaling ,0.6590792330496473,1.0
VLDL clearance ,0.6593365228500107,1.0
MECP2 regulates neuronal receptors and channels ,0.6599817894294301,0.9641782230533726
MAPK family signaling cascades ,0.6600168723984091,1.0
RHO GTPases Activate NADPH Oxidases ,0.6602315816829637,1.0
Creatine metabolism ,0.6627025696886962,1.0
TNFR1-mediated ceramide production ,0.6628878179644645,1.0
ADP signalling through P2Y purinoceptor 12 ,0.6629600864800638,1.0
Toll-like Receptor Cascades ,0.6631609488260006,0.8579003950692197
Diseases associated with surfactant metabolism ,0.6636020945211287,1.0
Mitotic Anaphase ,0.6682717736211834,0.8991003669310861
Endosomal Sorting Complex Required For Transport (ESCRT) ,0.6683706121888633,1.0
Elastic fibre formation ,0.6684588044784403,1.0
Protein folding ,0.6697906657560272,1.0
RHO GTPase Effectors ,0.6699213908305747,0.8235507692761893
Signalling to ERKs ,0.6704256886809556,1.0
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation ,0.6705400884597328,0.9988838185279454
Intracellular metabolism of fatty acids regulates insulin secretion ,0.6710240193496506,0.912336667316747
Signaling by NODAL ,0.6712297999898681,1.0
Intracellular signaling by second messengers ,0.6713043069659965,1.0
NOD1/2 Signaling Pathway ,0.6713158958841231,0.8973692095285671
MET Receptor Activation ,0.6717109811999201,0.8141381863163122
VLDLR internalisation and degradation ,0.6719487321395741,1.0
Unfolded Protein Response (UPR) ,0.6721487061333671,1.0
Downregulation of ERBB2:ERBB3 signaling ,0.6724152104379568,1.0
phospho-PLA2 pathway ,0.672418143697239,0.981279781882274
Glycolysis ,0.6728618575622053,0.8244821078064466
CLEC7A (Dectin-1) induces NFAT activation ,0.6731140648797533,1.0
Alternative complement activation ,0.6731769951646405,0.976063893646728
Regulated proteolysis of p75NTR ,0.6732003560765062,0.8266437634864577
Oncogene Induced Senescence ,0.6733507747897148,1.0
HDR through Homologous Recombination (HRR) ,0.6740377566878198,0.8415969736300782
Suppression of phagosomal maturation ,0.6741609701335616,1.0
Prolactin receptor signaling ,0.6742945707698039,1.0
Toll Like Receptor 9 (TLR9) Cascade ,0.6742979955284201,0.8294553029295749
G alpha (12/13) signalling events ,0.6746623077709788,0.953823614374073
RAF-independent MAPK1/3 activation ,0.6752165616346448,1.0
Regulation of pyruvate dehydrogenase (PDH) complex ,0.6752697949781832,0.8280526484137021
Degradation of DVL ,0.6752930070037892,1.0
Propionyl-CoA catabolism ,0.6756843878346904,0.9648523943011772
Signaling by FGFR1 in disease ,0.675808756746393,1.0
Autointegration results in viral DNA circles ,0.6759792209922354,1.0
Transcriptional activation of mitochondrial biogenesis ,0.6759927257165513,0.8930574988158435
SUMOylation ,0.6767119068714487,0.8582315209457325
Signaling by GPCR ,0.6768526631670836,1.0
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 ,0.6771184836990268,1.0
Netrin mediated repulsion signals ,0.6772725923578815,1.0
Diseases of carbohydrate metabolism ,0.6774600178005783,0.6897713906888219
Nucleobase catabolism ,0.6777721553894567,1.0
Endogenous sterols ,0.6782033070620354,0.8194018591469487
Mitochondrial ABC transporters ,0.6790178270867473,0.9629045190399268
Antagonism of Activin by Follistatin ,0.679358606617094,1.0
Scavenging by Class B Receptors ,0.6798076795666952,0.8300907354709253
Pink/Parkin Mediated Mitophagy ,0.6799133513642893,1.0
Zinc efflux and compartmentalization by the SLC30 family ,0.6801141250030551,0.8311207469746942
Negative regulation of TCF-dependent signaling by WNT ligand antagonists ,0.6807976795772589,1.0
Pausing and recovery of Tat-mediated HIV elongation ,0.68138179244745,1.0
Neuronal System ,0.6814400591327601,0.3443839766137333
Metallothioneins bind metals ,0.6826299740438838,0.9880322447814434
Metabolism of non-coding RNA ,0.6847217380940497,0.9811533537373032
Amine Oxidase reactions ,0.6854681126322894,1.0
Transmission across Chemical Synapses ,0.6856837192212913,0.4742642678422495
NOTCH3 Intracellular Domain Regulates Transcription ,0.6860742586899049,1.0
Cell-Cell communication ,0.6860879489695078,0.8453518958106114
Response of Mtb to phagocytosis ,0.6861718353843533,1.0
RAB GEFs exchange GTP for GDP on RABs ,0.6862195349329473,0.8445489271177344
Synthesis of Dolichyl-phosphate ,0.6869650520154393,1.0
Deadenylation of mRNA ,0.6871108056012509,0.9604741025255388
Signaling by moderate kinase activity BRAF mutants ,0.6871206257152999,1.0
Synthesis of diphthamide-EEF2 ,0.687193324165195,1.0
Activated NTRK3 signals through RAS ,0.6879464201006626,0.9880335902986102
Cytosolic tRNA aminoacylation ,0.6882090374836968,0.8309435970376273
Regulation of lipid metabolism by PPARalpha ,0.6912240016658099,0.8271131993799434
ABO blood group biosynthesis ,0.6923530053776118,0.9386905553196316
RHO GTPases activate KTN1 ,0.6924938887976837,0.9789939592169992
Defective SLC7A9 causes cystinuria (CSNU) ,0.6928847497308234,1.0
PKA activation ,0.6929211231754725,0.8458234426124335
Integration of viral DNA into host genomic DNA ,0.6930206476557602,1.0
Binding and Uptake of Ligands by Scavenger Receptors ,0.6932352616495221,0.9665963437032352
EPH-Ephrin signaling ,0.6933541488423735,0.8253592737537692
SHC1 events in EGFR signaling ,0.6939342191700802,1.0
Semaphorin interactions ,0.6940892620990801,1.0
RUNX3 Regulates Immune Response and Cell Migration ,0.6941359219722893,1.0
Regulation of beta-cell development ,0.6942686942185198,1.0
Defective LARGE causes MDDGA6 and MDDGB6 ,0.694778666911876,0.9648576918011972
Inhibition of Signaling by Overexpressed EGFR ,0.6949110307317825,1.0
HIV elongation arrest and recovery ,0.6951793476393153,0.8582568517634338
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD) ,0.695305923305845,0.9967042949227716
Circadian Clock ,0.6958647174740215,0.9740038429628836
Transport to the Golgi and subsequent modification ,0.6959896972519293,0.8233202407514333
IRAK4 deficiency (TLR5) ,0.6962096338950371,1.0
Synaptic adhesion-like molecules ,0.6962282007639438,1.0
Tat-mediated HIV elongation arrest and recovery ,0.6962522224728752,0.760773273971555
Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD ,0.6963724323889625,0.9578049105640506
betaKlotho-mediated ligand binding ,0.6966457988139313,1.0
Carboxyterminal post-translational modifications of tubulin ,0.6968774240199891,1.0
MyD88 dependent cascade initiated on endosome ,0.6970194052555952,0.8255927199262331
Fertilization ,0.697117692638249,1.0
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA ,0.69714415509638,0.7512572113842403
IRE1alpha activates chaperones ,0.6973593166352339,1.0
Signaling by RAS mutants ,0.6976013649157442,1.0
EGFR downregulation ,0.6984599517091971,0.9718067083332712
Pausing and recovery of HIV elongation ,0.6985318953693703,1.0
Paradoxical activation of RAF signaling by kinase inactive BRAF ,0.6990990221986046,1.0
Nucleotide salvage ,0.7005177787812553,1.0
Regulation of insulin secretion ,0.7009364525571378,1.0
mRNA decay by 5' to 3' exoribonuclease ,0.708176478046299,1.0
Regulation of TP53 Activity through Methylation ,0.7092503691330341,1.0
XBP1(S) activates chaperone genes ,0.7096370210555712,1.0
Glucagon-type ligand receptors ,0.7101356545887194,1.0
Thyroxine biosynthesis ,0.7101697896383233,0.9815571449293852
Glycogen breakdown (glycogenolysis) ,0.7102551693515756,0.8293706774275788
Diseases of Immune System ,0.7104616754636671,0.8440804171515359
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion ,0.7108633697990452,1.0
Termination of O-glycan biosynthesis ,0.7109941897288277,0.8362745651167692
ATF6 (ATF6-alpha) activates chaperones ,0.7113404370640002,1.0
Ub-specific processing proteases ,0.7114408810949165,0.8362228398925647
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde ,0.7117468463953656,0.9819787723744146
Synthesis of PS ,0.7117956778623582,1.0
Antigen processing-Cross presentation ,0.7118429846911047,1.0
Miscellaneous transport and binding events ,0.7119184858959066,0.9358702073479878
PI-3K cascade:FGFR3 ,0.7119233028861565,1.0
IRF3 mediated activation of type 1 IFN ,0.7120126554366295,0.8379547448452387
RAS signaling downstream of NF1 loss-of-function variants ,0.7122835838926066,1.0
Sodium-coupled phosphate cotransporters ,0.7123617400540083,0.9122961915242904
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake  ,0.7125032768717302,1.0
Defective SLC3A1 causes cystinuria (CSNU) ,0.7125294385954628,1.0
Defective LFNG causes SCDO3 ,0.7126499226961868,1.0
TFAP2 (AP-2) family regulates transcription of other transcription factors ,0.7129850715900178,1.0
RIP-mediated NFkB activation via ZBP1 ,0.7136949407601121,0.8470267722597419
PDE3B signalling ,0.7143101769096729,0.8887271641990149
Signaling by Rho GTPases ,0.7163690515395771,0.6674384831182162
TRAF3 deficiency - HSE ,0.7173318123872954,0.9987548033190448
TNFR1-induced proapoptotic signaling ,0.7182361735627062,1.0
Amplification of signal from the kinetochores ,0.7233402428925872,0.9649677046835968
NCAM1 interactions ,0.7245157189173002,1.0
Toll Like Receptor TLR1:TLR2 Cascade ,0.7248341519153546,0.8210368780510564
Norepinephrine Neurotransmitter Release Cycle ,0.7249706381348922,1.0
G alpha (i) signalling events ,0.7250090361036703,1.0
Extrinsic Pathway of Fibrin Clot Formation ,0.7264525711443075,0.9689589887976686
Detoxification of Reactive Oxygen Species ,0.7264862477804133,1.0
Metabolism of carbohydrates ,0.7272214174318401,0.6015299685024456
"Gamma carboxylation, hypusine formation and arylsulfatase activation ",0.7276316166687865,0.8935244211487304
Methionine salvage pathway ,0.7276870695808777,0.9430568439742752
TRIF-mediated programmed cell death ,0.72842066672163,1.0
Downstream TCR signaling ,0.7284240043495515,0.97097502959258
Negative regulation of activity of TFAP2 (AP-2) family transcription factors ,0.7287404063240029,1.0
Signal transduction by L1 ,0.7289239980464459,1.0
Late endosomal microautophagy ,0.7290308783980656,1.0
Regulation of IFNG signaling ,0.7291719927781478,0.9812664399820364
Signaling by PDGF ,0.7294118994534269,1.0
Type I hemidesmosome assembly ,0.7295666431108607,1.0
Synthesis of PG ,0.7300513395747595,0.9637985315226391
Toll Like Receptor 7/8 (TLR7/8) Cascade ,0.7304211734336852,0.8217817456191389
SUMO E3 ligases SUMOylate target proteins ,0.7304739873644086,0.6843337489528155
Nuclear Envelope Breakdown ,0.7304855033329746,0.9673834473247502
Cilium Assembly ,0.7314174016638176,0.4876698752054652
Apoptosis ,0.7323506038834119,1.0
Drug-mediated inhibition of ERBB2 signaling ,0.7323752764988939,1.0
O-glycosylation of TSR domain-containing proteins ,0.7343425273711391,1.0
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway ,0.7344569469421696,1.0
Choline catabolism ,0.7354463540399292,0.9827299656630472
Cholesterol biosynthesis ,0.7359938239826184,0.3090365292200155
Biosynthesis of EPA-derived SPMs ,0.7359979397627711,0.9985949235949236
Activation of the pre-replicative complex ,0.7360872931372876,0.8282048919716937
Glutathione conjugation ,0.7362594353270404,0.9580830752210682
Activated NTRK3 signals through PI3K ,0.7363878050439203,1.0
Ethanol oxidation ,0.7366450984749393,0.978011721786296
Negative regulators of DDX58/IFIH1 signaling ,0.7368869687851075,1.0
Inhibition of replication initiation of damaged DNA by RB1/E2F1 ,0.7388413823152039,0.9645596825657214
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal ,0.7401227442128628,0.9769275067440204
RAF/MAP kinase cascade ,0.7405856408668845,1.0
ER-Phagosome pathway ,0.7407651087637099,1.0
ABC transporters in lipid homeostasis ,0.7410902489868,0.8292290584033702
Platelet calcium homeostasis ,0.7412343350162945,1.0
Activation of the phototransduction cascade ,0.7413753744789219,0.9992973909699384
Mitotic Prometaphase ,0.7414887473814489,0.7393763095262312
G0 and Early G1 ,0.7419775827021712,0.964956768782652
Signaling by NTRK3 (TRKC) ,0.7420629252139309,1.0
Defective SLC7A7 causes lysinuric protein intolerance (LPI) ,0.7421821969268079,0.980667862970378
G2/M Checkpoints ,0.7427989333527577,0.9582687765508979
snRNP Assembly ,0.7432603543503835,0.9819562514948488
Amino Acid conjugation ,0.7439546423445039,0.8221628883798339
Cyclin A:Cdk2-associated events at S phase entry ,0.7458956355268717,1.0
RNA Polymerase III Abortive And Retractive Initiation ,0.7461260263399969,1.0
Regulation of PTEN stability and activity ,0.7461325263635279,1.0
Defective CHST6 causes MCDC1 ,0.7461389498530082,1.0
Signaling by Overexpressed Wild-Type EGFR in Cancer ,0.7462447150186364,1.0
Class A/1 (Rhodopsin-like receptors) ,0.7470480196420147,1.0
Signaling downstream of RAS mutants ,0.7476095575693892,1.0
Voltage gated Potassium channels ,0.7477308316702876,0.8280886134947743
Peroxisomal protein import ,0.7479151542470203,0.1784767220547037
Signaling by NTRK1 (TRKA) ,0.7480230926455701,1.0
MAP2K and MAPK activation ,0.7480399960712908,1.0
p53-Independent DNA Damage Response ,0.7481633345434814,1.0
Estrogen biosynthesis ,0.7484161016712613,1.0
Cysteine formation from homocysteine ,0.7484192446580581,0.9652844606973048
Vpu mediated degradation of CD4 ,0.7487198524547433,1.0
Transcriptional Regulation by E2F6 ,0.7488290814149263,0.9720299562350068
Glucose metabolism ,0.7490518135801392,0.8041702875939739
Toll Like Receptor 10 (TLR10) Cascade ,0.7491717998364495,0.8219231074735662
E2F mediated regulation of DNA replication ,0.74938025225243,0.9606693404939372
Leukotriene receptors ,0.7494478044805849,1.0
RNA polymerase II transcribes snRNA genes ,0.7497920756727168,1.0
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection ,0.7499121322793245,1.0
Dopamine receptors ,0.7500611924895041,1.0
Gap junction assembly ,0.7501946102861783,0.3902092967018867
Protein methylation ,0.7502241697361101,0.9630170923826
Electron transport from NADPH to Ferredoxin ,0.7506302070009242,0.9591909530450548
Synthesis of bile acids and bile salts via 24-hydroxycholesterol ,0.7506980605205266,0.8207613181925107
Metal sequestration by antimicrobial proteins ,0.7507237502989061,1.0
Astrocytic Glutamate-Glutamine Uptake And Metabolism ,0.7511129797555106,0.8312739124904369
Degradation of GLI1 by the proteasome ,0.7511407836624686,1.0
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) ,0.7512522723176711,0.9503155284270816
Formation of RNA Pol II elongation complex  ,0.751722717313244,1.0
TRKA activation by NGF ,0.752026529879235,1.0
Infection with Mycobacterium tuberculosis ,0.7526741993589395,1.0
RNA Pol II CTD phosphorylation and interaction with CE ,0.7527645609017637,1.0
IKBKB deficiency causes SCID ,0.7529539736801287,0.8266499086408065
Toll Like Receptor 2 (TLR2) Cascade ,0.7534151104463862,0.8306350343398201
Proton-coupled neutral amino acid transporters ,0.7544817615014204,0.962949943722174
MyD88 deficiency (TLR5) ,0.7550295295846534,0.9768756148985748
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling ",0.7550973557640754,1.0
Diseases associated with the TLR signaling cascade ,0.7553007855472572,0.829169843992185
ROBO receptors bind AKAP5 ,0.755558338300893,0.6433539133129217
Inflammasomes ,0.7556888780804165,0.9803136575089392
Opioid Signalling ,0.7557445299848922,1.0
Sterols are 12-hydroxylated by CYP8B1 ,0.7557614380615119,0.9804300162940772
Toll Like Receptor 5 (TLR5) Cascade ,0.7565991260364845,0.8341698870950636
DNA Repair ,0.756709567491005,0.850083694454003
Asparagine N-linked glycosylation ,0.7571449661345345,1.0
Recycling of eIF2:GDP ,0.7576698838239935,0.9630689060601586
Deubiquitination ,0.7582445027524793,0.8487109221054175
Neutrophil degranulation ,0.7582641102861181,0.2443617544534976
Carnitine synthesis ,0.7583078152972379,0.8291612944616792
Phospholipase C-mediated cascade; FGFR2 ,0.7583763862222679,0.9890785160241417
Pyruvate metabolism and Citric Acid (TCA) cycle ,0.758451866875779,0.3478924744979791
MyD88 cascade initiated on plasma membrane ,0.7584905535947183,0.8248639151956019
Downstream signaling events of B Cell Receptor (BCR) ,0.7584986327720621,0.9684090531702512
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation ,0.7588105677576744,0.8217836856157249
Unwinding of DNA ,0.7593279149540005,0.9720276753527004
IRAK4 deficiency (TLR2/4) ,0.7594822664217781,0.9977825508255797
Interleukin-37 signaling ,0.7596763247431614,0.9651937744478629
Activation of SMO ,0.7597541441011475,0.9648716333144041
Entry of Influenza Virion into Host Cell via Endocytosis ,0.7600731724129456,1.0
Toll Like Receptor 3 (TLR3) Cascade ,0.7604850041783294,0.8113114063699948
Reversal of alkylation damage by DNA dioxygenases ,0.7608639040081481,1.0
SUMOylation of transcription cofactors ,0.7611704159713549,1.0
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4) ,0.7618680117114912,1.0
mRNA Capping ,0.7621302354328356,1.0
Estrogen-dependent nuclear events downstream of ESR-membrane signaling ,0.7633278801847676,1.0
DDX58/IFIH1-mediated induction of interferon-alpha/beta ,0.7636052171739487,0.9586872255669288
Neurotransmitter uptake and metabolism In glial cells ,0.7636808626907917,0.8367575802938605
Negative regulation of the PI3K/AKT network ,0.7638057899699122,1.0
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling ,0.7640563175110987,1.0
Toll Like Receptor 4 (TLR4) Cascade ,0.7642381592064554,0.8306938474369667
RNA Polymerase II Transcription Elongation ,0.7643779721773247,1.0
Reelin signalling pathway ,0.7644557771626884,0.8364285471678888
Repression of WNT target genes ,0.7684500564778753,1.0
Telomere C-strand synthesis initiation ,0.7691737523322912,0.9233715655734004
SUMO is proteolytically processed ,0.7695788104187914,0.9731704371390668
HHAT G278V abrogates palmitoylation of Hh-Np ,0.7702400208404284,0.7478499711297876
Assembly Of The HIV Virion ,0.7703559696796634,0.9822899101936664
p53-Independent G1/S DNA damage checkpoint ,0.7706940691888161,1.0
Nuclear Envelope Reassembly ,0.7712866217211221,1.0
CDK-mediated phosphorylation and removal of Cdc6 ,0.772001504448127,1.0
SUMOylation of DNA replication proteins ,0.7721121609175826,0.9248279101596788
Constitutive Signaling by EGFRvIII ,0.7722926564008966,1.0
Hormone ligand-binding receptors ,0.7725228477566753,1.0
Presynaptic phase of homologous DNA pairing and strand exchange ,0.7729874569729097,0.8147280483714248
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain ,0.7731897139929865,0.9666304006900336
HIV Life Cycle ,0.773342307905616,1.0
Vpr-mediated nuclear import of PICs ,0.7734958084211511,0.9641809536530548
GLI3 is processed to GLI3R by the proteasome ,0.7735498797749338,1.0
Na+/Cl- dependent neurotransmitter transporters ,0.7736269220579396,0.9702663866475076
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis ,0.7740015132405511,1.0
N-Glycan antennae elongation ,0.7740213683826423,1.0
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5) ,0.7741043103655602,1.0
Establishment of Sister Chromatid Cohesion ,0.7743557619849867,0.8430719806866596
Apoptotic factor-mediated response ,0.7744237109330655,0.9810726025073984
Synthesis of UDP-N-acetyl-glucosamine ,0.7747659781241762,1.0
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A ,0.7750220697019233,1.0
Late Phase of HIV Life Cycle ,0.7753136714823097,1.0
RNA Polymerase III Transcription ,0.7756585529377268,1.0
FMO oxidises nucleophiles ,0.7759228419069462,1.0
Protein-protein interactions at synapses ,0.7761653484567029,1.0
Glycogen metabolism ,0.7762116741565773,0.7043444176785889
Resistance of ERBB2 KD mutants to lapatinib ,0.7762176240788454,1.0
Conjugation of carboxylic acids ,0.7763654406972709,0.8404083174725377
Resolution of Sister Chromatid Cohesion ,0.7764595976608913,0.8200684727508958
Netrin-1 signaling ,0.7765535222274843,1.0
Activated NOTCH1 Transmits Signal to the Nucleus ,0.7765775574206198,0.9649303957618628
Stimuli-sensing channels ,0.7767514743997763,1.0
Telomere Extension By Telomerase ,0.7769589207388502,1.0
Activation of NMDA receptors and postsynaptic events ,0.7769717318567076,0.8432830898265709
Biosynthesis of E-series 18(S)-resolvins ,0.7772584298677518,1.0
Cyclin D associated events in G1 ,0.777316367927945,0.9772165398850428
Metabolism of water-soluble vitamins and cofactors ,0.7773688815066527,0.8349799100793661
FGFR1c and Klotho ligand binding and activation ,0.7773946302257461,0.9602756287396907
Signaling by Leptin ,0.777492977963277,0.9516367250980317
G alpha (z) signalling events ,0.7775010014302075,1.0
Signal Transduction ,0.77753938007366,1.0
Cross-presentation of soluble exogenous antigens (endosomes) ,0.7776241731757203,1.0
Wax biosynthesis ,0.7777140076839059,1.0
Acyl chain remodeling of DAG and TAG ,0.7780545763925482,0.9983447377610134
Regulation of activated PAK-2p34 by proteasome mediated degradation ,0.7780645941436378,1.0
Phosphorylation of Emi1 ,0.7782672403231596,1.0
The activation of arylsulfatases ,0.7784600026175384,1.0
Trafficking of GluR2-containing AMPA receptors ,0.7785046337037993,0.7925571879700319
Programmed Cell Death ,0.7786433957448379,1.0
Breakdown of the nuclear lamina ,0.7786902315086053,0.9612602111767359
Ceramide signalling ,0.7787768951310083,1.0
Metabolism of polyamines ,0.7788189649229291,1.0
MyD88:MAL(TIRAP) cascade initiated on plasma membrane ,0.7790458243130021,0.8301055342164664
Regulation of PTEN localization ,0.7790796470714795,0.9354028998524412
Metabolism of steroids ,0.77909273028953,0.662519655966576
Regulation of PTEN gene transcription ,0.7792189042868688,1.0
Cam-PDE 1 activation ,0.7793433295720125,0.9679592862865746
Trafficking and processing of endosomal TLR ,0.7793590805091277,1.0
Cytosolic sensors of pathogen-associated DNA  ,0.7793650768911763,0.8209323312180685
"Platelet activation, signaling and aggregation ",0.7793950734458124,0.8284223926804865
mRNA decay by 3' to 5' exoribonuclease ,0.7797178212139233,1.0
ZBP1(DAI) mediated induction of type I IFNs ,0.779816915143705,0.7436000196634058
Heme degradation ,0.7798528814463934,0.9967608594543388
Termination of translesion DNA synthesis ,0.7799608480390056,0.9531150953414604
Transcription from mitochondrial promoters ,0.7799974928539165,0.7895111310707641
Toll Like Receptor TLR6:TLR2 Cascade ,0.7802341082742685,0.8367943684569328
Regulation of RUNX2 expression and activity ,0.7803743603527891,1.0
Interleukin-12 signaling ,0.7803823708221336,0.9662982277661176
Prostacyclin signalling through prostacyclin receptor ,0.7804857186888233,1.0
Platelet homeostasis ,0.7807684485061576,1.0
ERBB2 Regulates Cell Motility ,0.7809828508925123,1.0
RNA Polymerase II Transcription ,0.7809920910459852,1.0
Transport of fatty acids ,0.7811264692774552,1.0
Synthesis of PI ,0.7812680190380389,1.0
Diseases of metabolism ,0.7813454178252707,0.8260212044247759
Regulation of KIT signaling ,0.7817493864856424,0.9620954525041264
Glycosaminoglycan metabolism ,0.7818920141756152,1.0
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release ,0.7819269167929613,0.9843712997767884
RUNX3 regulates RUNX1-mediated transcription ,0.7819583917121506,1.0
2-LTR circle formation ,0.7820365369060778,1.0
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) ,0.7822243305119355,0.8275449604779028
Synthesis of wybutosine at G37 of tRNA(Phe) ,0.7829842150650667,0.8294447652245817
Regulation of Apoptosis ,0.7843335432981845,1.0
Peroxisomal lipid metabolism ,0.7845249860735952,0.23511674510055516
Mitophagy ,0.7847781033381329,1.0
Resistance of ERBB2 KD mutants to sapitinib ,0.7855226447467494,1.0
NrCAM interactions ,0.7862198351016527,1.0
TLR3-mediated TICAM1-dependent programmed cell death ,0.7865095335152491,1.0
AUF1 (hnRNP D0) binds and destabilizes mRNA ,0.7871097009302147,1.0
Resistance of ERBB2 KD mutants to neratinib ,0.7886583851684059,1.0
Digestion ,0.7887934131177533,0.8201882282057791
Androgen biosynthesis ,0.7891433858481103,0.8177595508094501
Deactivation of the beta-catenin transactivating complex ,0.7892596588853493,1.0
TRIF(TICAM1)-mediated TLR4 signaling  ,0.7895983386755233,0.8235409683665851
Glycine degradation ,0.7896098179854453,1.0
Class B/2 (Secretin family receptors) ,0.7898990814404487,0.8870498591034935
SLC transporter disorders ,0.7899567385633667,0.9266568294091229
Regulation of mRNA stability by proteins that bind AU-rich elements ,0.7908652555709497,1.0
Autophagy ,0.7910245123246052,1.0
MECP2 regulates transcription factors ,0.7915237057329442,0.9676462364016456
Synthesis of PIPs at the plasma membrane ,0.7922756290479198,0.965498969168694
PTEN Regulation ,0.7929741454701449,1.0
RAS GTPase cycle mutants ,0.7930233108437753,0.9831079377766212
G1 Phase ,0.7930755889257897,0.9811934782253184
HSP90 chaperone cycle for steroid hormone receptors (SHR) ,0.7934123700731875,0.8303168586902221
ABC-family proteins mediated transport ,0.7934854279643704,0.90988145980943
Pyrimidine catabolism ,0.7936791725539024,1.0
PLC beta mediated events ,0.794403973464355,0.9671420518288936
RNA Polymerase III Transcription Initiation From Type 1 Promoter ,0.7945456919183048,1.0
DNA replication initiation ,0.7950497049750476,0.9172880057202342
Chaperonin-mediated protein folding ,0.7950912084562699,1.0
mRNA Editing: C to U Conversion ,0.795171206402387,0.9883253772289252
Post-translational modification: synthesis of GPI-anchored proteins ,0.7954943834140522,0.9647884077488657
Regulation of FZD by ubiquitination ,0.7955199284646343,1.0
Biosynthesis of E-series 18(R)-resolvins ,0.7957474585856392,1.0
Lysosomal oligosaccharide catabolism ,0.7958348487975051,0.8625543445115311
Formation of the Editosome ,0.7962709969471782,0.9749309906107236
"Metabolism of ingested SeMet, Sec, MeSec into H2Se ",0.7964149927450459,0.8877461914999146
SUMOylation of transcription factors ,0.7966067801284614,0.9367366407064598
Regulation of cholesterol biosynthesis by SREBP (SREBF) ,0.7966339791244365,0.9234987305218244
Formation of apoptosome ,0.7969831541926287,1.0
Processing of SMDT1 ,0.7970040643856062,1.0
Synthesis of pyrophosphates in the cytosol ,0.7973964750688858,0.9987842707489352
Diseases of Mismatch Repair (MMR) ,0.7975190115618814,1.0
Transcription of the HIV genome ,0.7980165604208868,1.0
Ion channel transport ,0.7980526059319214,1.0
Ubiquitin-dependent degradation of Cyclin D ,0.7985587814239038,1.0
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes ,0.79858393618431,0.8576977399991553
Resistance of ERBB2 KD mutants to tesevatinib ,0.7986104821189417,1.0
"Activation of NIMA Kinases NEK9, NEK6, NEK7 ",0.7999137736493663,0.9805045871559632
Regulation of Glucokinase by Glucokinase Regulatory Protein ,0.8015251147190151,0.9590537407886603
Peptide ligand-binding receptors ,0.8017294801850073,1.0
Depolymerisation of the Nuclear Lamina ,0.8021189936100961,1.0
Signaling by NOTCH3 ,0.8021918456798603,1.0
"Activation, myristolyation of BID and translocation to mitochondria ",0.8025015260655319,1.0
Platelet sensitization by LDL ,0.8027417261509702,0.9996828455385874
PPARA activates gene expression ,0.8029046786849625,0.8236905668098329
Ficolins bind to repetitive carbohydrate structures on the target cell surface ,0.8031040430659293,1.0
Activated NTRK3 signals through PLCG1 ,0.8031914094084588,0.8790343125667306
Generic Transcription Pathway ,0.8032017906669127,1.0
Plasmalogen biosynthesis ,0.8033103980959637,0.8784011067584581
mTOR signalling ,0.8034164891475797,0.9695473869662816
Signaling by EGFRvIII in Cancer ,0.8037474222951706,1.0
GABA receptor activation ,0.8038792598518514,0.8259674747921856
Ketone body metabolism ,0.8039418395319398,0.9597946964135706
RUNX1 regulates estrogen receptor mediated transcription ,0.8040305364932865,0.841466446397639
Extra-nuclear estrogen signaling ,0.8041147556363678,1.0
Signaling by Activin ,0.8048693866330062,1.0
POLB-Dependent Long Patch Base Excision Repair ,0.805385731243726,1.0
Biological oxidations ,0.8053889178914181,0.23647911721306214
Terminal pathway of complement ,0.8061335684455009,0.6873346567086448
"Synthesis, secretion, and deacylation of Ghrelin ",0.8063341212661529,0.8946011615503141
ATF4 activates genes in response to endoplasmic reticulum  stress ,0.8064312106765205,1.0
HIV Infection ,0.8068536074874391,1.0
RAB geranylgeranylation ,0.8069449041663096,0.9738391141123258
"Plasma lipoprotein assembly, remodeling, and clearance ",0.8070612944248499,0.8404976944538254
Hydroxycarboxylic acid-binding receptors ,0.8070941346935266,1.0
Defective MMAA causes methylmalonic aciduria type cblA ,0.8071218314621873,1.0
NGF processing ,0.8072351839268215,1.0
Activation of Na-permeable kainate receptors ,0.8073598914325545,0.9793462651000008
Highly calcium permeable nicotinic acetylcholine receptors ,0.8073808273399193,1.0
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members ,0.8077388566456243,0.8196187173006279
HS-GAG degradation ,0.8077645119317708,0.9833322640662092
Transfer of LPS from LBP carrier to CD14 ,0.807855500962009,1.0
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest ,0.8079579527165874,0.9855148310855936
Host Interactions of HIV factors ,0.8080894282637545,1.0
Pre-NOTCH Processing in Golgi ,0.8084664276215731,1.0
Defective EXT2 causes exostoses 2 ,0.8084687171813622,1.0
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS ",0.8084820090980072,1.0
Vitamin B2 (riboflavin) metabolism ,0.8086918170429617,1.0
Digestion of dietary lipid ,0.8096021004560362,0.9748861230512608
Signaling by Hippo ,0.8099997779217921,0.8258611083233259
Glycogen storage disease type 0 (liver GYS2) ,0.8102758013865337,0.9670339994024416
Autodegradation of the E3 ubiquitin ligase COP1 ,0.8102831526535834,1.0
Suppression of autophagy ,0.8117321657923008,0.9599589401424264
PI-3K cascade:FGFR1 ,0.8123971582666372,1.0
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization ,0.8124601616522007,0.9809843330152236
E2F-enabled inhibition of pre-replication complex formation ,0.8130419779953926,1.0
S Phase ,0.8136441708605908,0.9677921375443762
Assembly and cell surface presentation of NMDA receptors ,0.8141131336517228,0.965039353817938
PTK6 promotes HIF1A stabilization ,0.8143469944247199,0.9834914937243802
Hypusine synthesis from eIF5A-lysine ,0.8152435217021758,1.0
Cytochrome c-mediated apoptotic response ,0.8155557622671461,0.98261850225153
NIK-->noncanonical NF-kB signaling ,0.8157653581960244,1.0
Mitochondrial transcription initiation ,0.8172568358505871,0.8170725850076128
SCF-beta-TrCP mediated degradation of Emi1 ,0.8175853938027057,1.0
Beta oxidation of palmitoyl-CoA to myristoyl-CoA ,0.8176751830294564,0.917000430886725
Cellular response to hypoxia ,0.8186393778296448,1.0
Activated NTRK2 signals through CDK5 ,0.8190254177886734,0.9583266504138064
MyD88-independent TLR4 cascade  ,0.8192701674121508,0.8243496737524779
Negative regulation of TCF-dependent signaling by DVL-interacting proteins ,0.8194723549436849,1.0
PLCG1 events in ERBB2 signaling ,0.8196000232842122,0.971453702938323
Dectin-1 mediated noncanonical NF-kB signaling ,0.8205284709483763,1.0
G alpha (q) signalling events ,0.8207074693103364,1.0
Thromboxane signalling through TP receptor ,0.8210415822590553,1.0
IKK complex recruitment mediated by RIP1 ,0.8213740021223875,0.9613751552867482
Cell Cycle ,0.8215776537941091,0.2993776865336498
Resistance of ERBB2 KD mutants to trastuzumab ,0.8216427548897874,1.0
Post NMDA receptor activation events ,0.8216848822119629,0.9128224202754222
G2/M DNA replication checkpoint ,0.8222142199846,0.9403498642030752
Resistance of ERBB2 KD mutants to AEE788 ,0.8227935604059959,1.0
Drug resistance in ERBB2 KD mutants ,0.8247057963238641,1.0
Caspase activation via Death Receptors in the presence of ligand ,0.8252683708934943,1.0
Defective Mismatch Repair Associated With PMS2 ,0.8268964125430673,1.0
Agmatine biosynthesis ,0.8270245529089795,1.0
Acetylation ,0.8277061965511501,0.8698028040645691
EPHA-mediated growth cone collapse ,0.8284063793093918,0.8385832356713888
Localization of the PINCH-ILK-PARVIN complex to focal adhesions ,0.8284679341930954,1.0
"Cobalamin (Cbl, vitamin B12) transport and metabolism ",0.8285431527565098,0.8261363465735904
Chondroitin sulfate biosynthesis ,0.8293641398908437,0.9620308692651356
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells ,0.8293712832324799,1.0
HIV Transcription Elongation ,0.8294753238304049,1.0
SCF(Skp2)-mediated degradation of p27/p21 ,0.8296571014188666,1.0
Synthesis of PIPs at the ER membrane ,0.8299391702699492,0.9714300081272558
Synthesis of IPs in the nucleus ,0.8300516733339507,0.8349414130961647
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain ,0.8300571046453181,0.8512955169376015
Transport of organic anions ,0.8310483381533168,1.0
Downregulation of ERBB2 signaling ,0.8313263252456246,1.0
Constitutive Signaling by Aberrant PI3K in Cancer ,0.8313458488061958,1.0
Resistance of ERBB2 KD mutants to afatinib ,0.8315873470507054,1.0
Activation of BIM and translocation to mitochondria  ,0.8318431666554486,0.9642730180987826
Assembly of active LPL and LIPC lipase complexes ,0.8326000877581601,0.8595357915488251
Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE ,0.8328377513673685,0.9126269564899391
Glucagon signaling in metabolic regulation ,0.8332674304717207,1.0
TFAP2 (AP-2) family regulates transcription of cell cycle factors ,0.8342730977203929,0.9982354951875946
Laminin interactions ,0.8346337303901676,0.9669257831908828
Pyrimidine biosynthesis ,0.8348132026880822,0.9653879831760818
Interleukin-36 pathway ,0.8348385228226716,0.8822313743874347
Initiation of Nuclear Envelope Reformation ,0.8348428405827669,1.0
Regulation of TP53 Activity through Phosphorylation ,0.8361248918624009,0.7106048106177323
Non-integrin membrane-ECM interactions ,0.8362853845545878,1.0
Translesion synthesis by REV1 ,0.8363684916388743,1.0
Transcriptional Regulation by TP53 ,0.8365678016018023,0.7844968846587843
RNA Polymerase I Transcription Initiation ,0.8365902786581499,1.0
PTK6 Regulates Proteins Involved in RNA Processing ,0.8366044562385697,0.8417804074030334
Deadenylation-dependent mRNA decay ,0.8367533967226064,0.9749531237327672
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway ,0.8367796379758896,1.0
Signalling to ERK5 ,0.8369589275316921,0.9633145502168968
Regulation of FOXO transcriptional activity by acetylation ,0.8372955661496739,0.8911020672128374
The role of GTSE1 in G2/M progression after G2 checkpoint ,0.8373414779139553,1.0
tRNA processing in the mitochondrion ,0.8373513801928563,0.9973528691457476
TP53 Regulates Transcription of Caspase Activators and Caspases ,0.8374876804395486,1.0
Metalloprotease DUBs ,0.8375326497283252,0.9890423881249568
UNC93B1 deficiency - HSE ,0.8376278274740029,0.96149658724509
EGFR interacts with phospholipase C-gamma ,0.8376846653849856,1.0
Macroautophagy ,0.8377825429283491,1.0
Interactions of Vpr with host cellular proteins ,0.8387268878102894,0.962137350134292
Defective MTR causes methylmalonic aciduria and homocystinuria type cblG ,0.8389019354962529,0.9362747344398722
G-protein activation ,0.8390563859560732,1.0
NFG and proNGF binds to p75NTR ,0.8393307384457239,1.0
Vasopressin regulates renal water homeostasis via Aquaporins ,0.8393594248779358,0.91043641059959
Polo-like kinase mediated events ,0.8393898995690562,0.9667242231879428
PI-3K cascade:FGFR4 ,0.8399455867329864,1.0
Regulation of RUNX3 expression and activity ,0.8400083693930998,1.0
Bicarbonate transporters ,0.8401765387159706,0.9736600442721663
Vitamins ,0.8405108933449856,0.9800962828485764
TP53 Regulates Transcription of Cell Death Genes ,0.8407840042114104,0.9590772560520076
Fructose catabolism ,0.8408649653757345,0.9651692868394136
Gap-filling DNA repair synthesis and ligation in TC-NER ,0.8410716070092839,1.0
Resistance of ERBB2 KD mutants to osimertinib ,0.8414447561571509,1.0
Anchoring of the basal body to the plasma membrane ,0.8416200690483657,0.8202014924606035
Signaling by MET ,0.8416643226501418,1.0
RUNX2 regulates chondrocyte maturation ,0.8419055496460254,0.9804663377548191
Interleukin-1 signaling ,0.8422574460980164,0.8246294989414255
PI Metabolism ,0.8428816286366717,0.9389956812125558
CLEC7A (Dectin-1) signaling ,0.84324551117476,0.8456356759109052
RHO GTPases regulate CFTR trafficking ,0.8436085190556741,0.9686199010528656
Disinhibition of SNARE formation ,0.8439594921551105,0.8458988670703561
Intestinal infectious diseases ,0.8443563976551907,1.0
HS-GAG biosynthesis ,0.8450144051918879,1.0
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) ,0.8454624395501265,0.9666769043306228
Regulation of innate immune responses to cytosolic DNA ,0.8459706792914532,1.0
RHO GTPases Activate ROCKs ,0.8462635005043868,1.0
Coenzyme A biosynthesis ,0.8464193180554606,1.0
Synthesis of bile acids and bile salts via 27-hydroxycholesterol ,0.8471222331838749,0.8429531365782869
CDT1 association with the CDC6:ORC:origin complex ,0.8476393982528956,1.0
Translesion synthesis by POLK ,0.8481823195581903,0.977306249557217
Defective Mismatch Repair Associated With MLH1 ,0.8483016316691601,1.0
Signaling by plasma membrane FGFR1 fusions ,0.8485577196187475,1.0
Translesion Synthesis by POLH ,0.8490436227441625,1.0
Mitotic G1 phase and G1/S transition ,0.8512730714742186,1.0
Biosynthesis of aspirin-triggered D-series resolvins ,0.8514812101624732,1.0
MET activates STAT3 ,0.8517066278136225,0.8232637248240274
Defective B3GALT6 causes EDSP2 and SEMDJL1 ,0.8518153559573072,1.0
NTRK3 as a dependence receptor ,0.8519806669195986,1.0
Rho GTPase cycle ,0.8519975517464348,1.0
eNOS activation ,0.8522582612370628,0.9869259181185788
Nuclear Pore Complex (NPC) Disassembly ,0.8523190778934508,0.8217160872831377
Gap junction trafficking ,0.8524452924813835,0.6609894872172261
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA ,0.8525007590748163,1.0
Arachidonate production from DAG ,0.8526451197408207,0.8213563534664453
Defective CHSY1 causes TPBS ,0.8528088067966074,0.8301720341054195
Defective GALNT12 causes colorectal cancer 1 (CRCS1) ,0.8528710004171688,1.0
"TICAM1, RIP1-mediated IKK complex recruitment ",0.8531744214141652,0.8786122134745988
Class I MHC mediated antigen processing & presentation ,0.8533591275873952,0.7479041687612121
Heparan sulfate/heparin (HS-GAG) metabolism ,0.8534326619866339,1.0
Expression and Processing of Neurotrophins ,0.8535363440765361,1.0
Activated NTRK2 signals through RAS ,0.8538241728090863,1.0
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) ,0.853888959608552,1.0
The canonical retinoid cycle in rods (twilight vision) ,0.8542060374392402,0.9795029772789016
STAT6-mediated induction of chemokines ,0.8543237416315365,1.0
Gap junction trafficking and regulation ,0.8543274322001541,0.4717773625457112
NOTCH1 Intracellular Domain Regulates Transcription ,0.8546846008844573,1.0
Recruitment of mitotic centrosome proteins and complexes ,0.8547123331365342,0.8243682922582004
Arachidonic acid metabolism ,0.8549189362620524,0.9663630416325788
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD ,0.8549600180713338,1.0
VEGF ligand-receptor interactions ,0.8550603914686549,0.9369803833511336
"Defective B4GALT7 causes EDS, progeroid type ",0.8553691772922474,1.0
OAS antiviral response ,0.8556457205921651,0.7899817573730619
Vesicle-mediated transport ,0.8558281222256333,0.19340903744573468
N-glycan trimming and elongation in the cis-Golgi ,0.8560469023305112,1.0
Transport of nucleotide sugars ,0.8563630315015631,1.0
Amino acids regulate mTORC1 ,0.8574751957388672,0.8785211505942084
Acetylcholine regulates insulin secretion ,0.8582231398139116,1.0
Diseases of signal transduction ,0.8588827415186424,1.0
CREB3 factors activate genes ,0.8592312601194494,0.9741520426400904
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) ,0.8594448815761967,0.9622037407352532
RNA Polymerase II Pre-transcription Events ,0.8597342158908943,1.0
Smooth Muscle Contraction ,0.8597382228973649,1.0
Diseases associated with glycosylation precursor biosynthesis ,0.8598514294418623,0.9627531928912112
Activation of PUMA and translocation to mitochondria ,0.8603506585403926,0.8348905085112199
Glyoxylate metabolism and glycine degradation ,0.860494921432481,1.0
TP53 Regulates Transcription of DNA Repair Genes ,0.8605460336256094,0.9514036874210122
Phospholipid metabolism ,0.8607963475714508,0.8230524635914543
Intrinsic Pathway for Apoptosis ,0.861056764876712,0.9577043653122592
Biosynthesis of protectins ,0.8621266094445881,0.9630765040987848
Cardiac conduction ,0.8623698143944156,1.0
Cation-coupled Chloride cotransporters ,0.8627075316409522,1.0
Recycling pathway of L1 ,0.8628644880306775,0.9371363587689504
TAK1 activates NFkB by phosphorylation and activation of IKKs complex ,0.8632642536377336,0.6596792198627061
Metabolism of cofactors ,0.8634407210502406,1.0
Oncogenic MAPK signaling ,0.8636045622852742,1.0
O2/CO2 exchange in erythrocytes ,0.8639112488581187,0.8204416170429514
Potassium Channels ,0.8640403351613847,0.8773440184097819
SUMOylation of SUMOylation proteins ,0.8642697441552591,0.9650266868378736
Regulation of RAS by GAPs ,0.8645953310841572,1.0
Glucuronidation ,0.8648617901994259,1.0
Vitamin D (calciferol) metabolism ,0.8650855134312339,1.0
Glutathione synthesis and recycling ,0.8651266003831077,0.9635601746121528
Defective CD320 causes methylmalonic aciduria ,0.8651377319788996,1.0
Budding and maturation of HIV virion ,0.8653955483978019,1.0
Formation of HIV-1 elongation complex containing HIV-1 Tat ,0.8654866093108459,0.8937261572825312
Signaling by FGFR3 point mutants in cancer ,0.8655319258714637,1.0
Transcriptional  activation of  cell cycle inhibitor p21  ,0.8662265223247146,0.8328101052871695
Synthesis of substrates in N-glycan biosythesis ,0.8662734370454226,1.0
NCAM signaling for neurite out-growth ,0.8669552785091019,1.0
GRB2:SOS provides linkage to MAPK signaling for Integrins  ,0.8670670762366531,1.0
Signaling by EGFR in Cancer ,0.8671208265481123,1.0
Export of Viral Ribonucleoproteins from Nucleus ,0.8671724903259588,0.8321533924921364
VEGF binds to VEGFR leading to receptor dimerization ,0.8675102061584901,0.960372242744018
Nitric oxide stimulates guanylate cyclase ,0.8675411727064866,1.0
A tetrasaccharide linker sequence is required for GAG synthesis ,0.8675681925348622,1.0
Synthesis of active ubiquitin: roles of E1 and E2 enzymes ,0.867580867021073,1.0
ABC transporter disorders ,0.8676848609077563,1.0
Insulin processing ,0.8676881205222354,1.0
Defective MUT causes methylmalonic aciduria mut type ,0.8677124292183707,1.0
Transport of Ribonucleoproteins into the Host Nucleus ,0.8677470273703958,0.8676846404180457
Signaling by PTK6 ,0.8679329847518782,0.8352763921857959
Telomere C-strand (Lagging Strand) Synthesis ,0.8679444427041072,0.9710151959338108
Signaling by FGFR3 in disease ,0.8681037456145745,1.0
NEP/NS2 Interacts with the Cellular Export Machinery ,0.8681115883580101,0.8961316657152931
DNA Damage Reversal ,0.8681177108633138,1.0
"Sodium-coupled sulphate, di- and tri-carboxylate transporters ",0.8681661082708139,0.9812285514813612
Biosynthesis of maresins ,0.8681703037696534,0.8301286911587161
M Phase ,0.8682370705615146,0.6197603480756108
Defective NEU1 causes sialidosis ,0.8682969144486777,1.0
Mitotic Telophase/Cytokinesis ,0.8682970832447897,0.964818521361825
Erythrocytes take up carbon dioxide and release oxygen ,0.8683053740480653,0.817535867000408
SUMOylation of immune response proteins ,0.8683246315686488,0.9643444331210778
Organic anion transport ,0.8683410127340377,1.0
Transcriptional activation of p53 responsive genes   ,0.868372083963948,0.8340654592450768
CYP2E1 reactions ,0.8684757541704549,1.0
SUMOylation of DNA damage response and repair proteins ,0.8684781879299692,0.8240447923822282
ERK/MAPK targets ,0.8686119520328617,1.0
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors ,0.8686769879053675,0.982710017013966
Developmental Biology ,0.8686770413155644,0.18784243279656124
Sulfide oxidation to sulfate ,0.868727441394942,0.9638428658497464
Ca2+ pathway ,0.8688165234562557,1.0
Cohesin Loading onto Chromatin ,0.8690165977472507,0.8698979453138992
Abortive elongation of HIV-1 transcript in the absence of Tat ,0.8690210471991662,1.0
Assembly of the pre-replicative complex ,0.8691256073726938,1.0
Serotonin receptors ,0.8691553464310963,1.0
Defective AMN causes hereditary megaloblastic anemia 1 ,0.8692389030260186,0.9516794381301872
"SUMO is transferred from E1 to E2 (UBE2I, UBC9) ",0.8692571262477103,0.9842317036772562
Aflatoxin activation and detoxification ,0.8692652516839798,0.9726125047225964
Degradation of beta-catenin by the destruction complex ,0.8692796884734231,1.0
NS1 Mediated Effects on Host Pathways ,0.8693030980367222,0.9571986859348969
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis  ,0.8693639967021917,0.929868696837692
Crosslinking of collagen fibrils ,0.8694195722543727,1.0
Defects in cobalamin (B12) metabolism ,0.8694726500592544,0.8857466502658633
Gene expression (Transcription) ,0.8696832130805865,1.0
Histamine receptors ,0.8697112383086556,0.9114633439258862
Nuclear Events (kinase and transcription factor activation) ,0.8698734199302367,1.0
Reversible hydration of carbon dioxide ,0.8700171163430871,0.8796104684732805
E3 ubiquitin ligases ubiquitinate target proteins ,0.8700681129495277,0.9593445198115756
Signaling by FGFR in disease ,0.8701399762367423,1.0
Chondroitin sulfate/dermatan sulfate metabolism ,0.8701464079133338,1.0
"Synthesis And Processing Of GAG, GAGPOL Polyproteins ",0.8701567786367548,0.9713441270989228
N-glycan antennae elongation in the medial/trans-Golgi ,0.8701713656191646,0.9663735507646529
Dual incision in TC-NER ,0.8702097619717211,1.0
G1/S Transition ,0.8702553647245516,1.0
Cargo recognition for clathrin-mediated endocytosis ,0.8703259621378707,0.8362514891117158
Interleukin-1 family signaling ,0.8703360550159486,0.8382883976338291
Biosynthesis of D-series resolvins ,0.8705577978850304,1.0
Defective ABCA1 causes Tangier disease ,0.8706348865625702,0.9812239628656512
Scavenging by Class A Receptors ,0.87066454803886,0.988453226913872
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS) ,0.8708404838098605,0.9863649125175884
Activation of NOXA and translocation to mitochondria ,0.8708836928631192,0.8358033403904963
Transport of Mature Transcript to Cytoplasm ,0.8709040584847451,1.0
Negative regulation of FGFR2 signaling ,0.8710150140571019,0.981847074643438
Glycogen synthesis ,0.8713946680835872,0.8291926661292437
Physiological factors ,0.8716219233799342,1.0
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux ,0.8716961861900792,1.0
Association of TriC/CCT with target proteins during biosynthesis ,0.8718006973375746,0.8204361150029448
"Cell Cycle, Mitotic ",0.8721492201958556,0.7008538097987639
Regulation of PLK1 Activity at G2/M Transition ,0.8722108985512986,0.8876120057312719
MAPK targets/ Nuclear events mediated by MAP kinases ,0.8723578214561901,1.0
RUNX3 regulates YAP1-mediated transcription ,0.8723962542908026,0.8284962142685107
Viral Messenger RNA Synthesis ,0.87274503327727,0.9801428134676048
Proline catabolism ,0.8727985141346376,0.8968161258591653
Ion homeostasis ,0.8730959087422029,1.0
Keratan sulfate degradation ,0.8731579400025439,1.0
RNA Polymerase III Transcription Initiation From Type 2 Promoter ,0.8732483111611928,1.0
Chaperone Mediated Autophagy ,0.8733006458307814,0.9741206373617954
Defective B3GAT3 causes JDSSDHD ,0.873325008291149,1.0
Small interfering RNA (siRNA) biogenesis ,0.8733633998598226,1.0
Host Interactions with Influenza Factors ,0.8733897302140742,0.9602905147181504
Sema4D in semaphorin signaling ,0.8734053953598044,1.0
Rap1 signalling ,0.8735290510611733,0.9579058976745456
Adenosine P1 receptors ,0.8736737033811052,0.8129115762960177
DNA Damage Bypass ,0.8739643150903684,0.8797492077308591
EML4 and NUDC in mitotic spindle formation ,0.8739675846164366,0.9384200653142
Regulation of gap junction activity ,0.8740369283384434,0.8401472633811361
Intrinsic Pathway of Fibrin Clot Formation ,0.8742702554318829,0.9514666477383636
Fatty acids ,0.8743407888176193,1.0
Formation of Senescence-Associated Heterochromatin Foci (SAHF) ,0.8743784173566073,0.9616570107196354
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose ,0.874379819092559,0.956895013834937
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling ,0.8751286329134709,1.0
Biosynthesis of DPAn-6 SPMs ,0.875142133404317,0.9750066326878586
FBXW7 Mutants and NOTCH1 in Cancer ,0.8753532101523208,1.0
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) ,0.8754827146117579,0.96186697813789
Pentose phosphate pathway ,0.8756958492322646,0.9249881816223888
Signaling by Hedgehog ,0.8756977014794685,0.8868910783946913
G beta:gamma signalling through PLC beta ,0.8758847464962515,1.0
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia ,0.8762151747549632,1.0
Loss of Function of TGFBR2 in Cancer ,0.8764116438794994,0.9660505166873744
MET receptor recycling ,0.8765371291265941,0.9859458828871815
Regulation of signaling by NODAL ,0.8766209560049012,0.9789217792123152
Calnexin/calreticulin cycle ,0.8770185298404943,1.0
Gluconeogenesis ,0.8772940467829986,0.8349708768146896
Binding of TCF/LEF:CTNNB1 to target gene promoters ,0.8773047667249608,1.0
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) ,0.8778894975024584,1.0
Axonal growth stimulation ,0.8781733733048571,1.0
The phototransduction cascade ,0.8782793813809835,1.0
Interactions of Rev with host cellular proteins ,0.8804504260099806,0.8302497800111125
Kinesins ,0.8806557842697061,0.8151234902759952
Activation of NF-kappaB in B cells ,0.8817560204279806,1.0
TRAF6 mediated NF-kB activation ,0.8836370591842059,0.6115336889559311
Hedgehog 'off' state ,0.8837267934575117,0.96260017576449
Integration of energy metabolism ,0.8839586179169873,0.8305132159624498
Electric Transmission Across Gap Junctions ,0.8843410007849837,0.8229873567800734
Membrane Trafficking ,0.8844021250476127,0.2468403156476551
Diseases of Base Excision Repair ,0.8856365504435211,1.0
G-protein beta:gamma signalling ,0.8861190561124208,1.0
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA ,0.8864253369304461,1.0
TRP channels ,0.8868521036307542,0.9697970919822464
Scavenging by Class H Receptors ,0.8875290131131843,1.0
Heme biosynthesis ,0.8875676293175019,0.9732555005303392
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs ,0.8878182117015003,1.0
Hydrolysis of LPE ,0.8878231134736221,0.9854130839987532
NGF-independant TRKA activation ,0.8881235222916377,1.0
"Inactivation, recovery and regulation of the phototransduction cascade ",0.8884136554096367,1.0
Ion transport by P-type ATPases ,0.8884366695359445,1.0
UCH proteinases ,0.8886699377678052,0.968450382441208
Intraflagellar transport ,0.8894782808990214,0.8367762753757199
Downstream signaling of activated FGFR3 ,0.8895035265912029,1.0
Regulation of the apoptosome activity ,0.889521715643564,1.0
CaMK IV-mediated phosphorylation of CREB ,0.8895920724408679,1.0
Tie2 Signaling ,0.8903353071298706,1.0
FRS-mediated FGFR1 signaling ,0.8904795402898474,0.9859987340903372
Hh mutants abrogate ligand secretion ,0.8917923873240021,1.0
RUNX3 regulates NOTCH signaling ,0.8919341663222055,1.0
Cellular hexose transport ,0.8925547247626167,0.9820059533420264
MECP2 regulates transcription of genes involved in GABA signaling ,0.8927500680272239,0.9179677105869012
Golgi Associated Vesicle Biogenesis ,0.8938884549292891,0.8254977002028117
Phenylalanine metabolism ,0.8947153362494497,0.8562202323670214
SLBP independent Processing of Histone Pre-mRNAs ,0.8951564732122299,1.0
Defective ABCG5 causes sitosterolemia ,0.8951987902794349,1.0
PI3K events in ERBB2 signaling ,0.8952850441816756,1.0
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) ,0.8954402135669786,0.7836694480443201
Activated point mutants of FGFR2 ,0.8957397147751376,0.9732018518740312
Alpha-protein kinase 1 signaling pathway ,0.8960848171755309,0.9872750489898704
Diseases of glycosylation ,0.8961568997842492,1.0
Defective CFTR causes cystic fibrosis ,0.8964186107899829,1.0
Transcriptional regulation of white adipocyte differentiation ,0.8968907313263473,1.0
Recruitment of NuMA to mitotic centrosomes ,0.8972082662433843,0.7959564402199182
Phospholipase C-mediated cascade; FGFR4 ,0.8981303822782796,0.966196861588914
Resolution of Abasic Sites (AP sites) ,0.8981773431937298,1.0
TYSND1 cleaves peroxisomal proteins ,0.8983174644851618,0.8451267717322762
Disorders of transmembrane transporters ,0.8984621296926086,0.8625350714323372
mTORC1-mediated signalling ,0.8988598828143242,0.9989103764506224
Hedgehog 'on' state ,0.8990203322693769,1.0
Josephin domain DUBs ,0.8999724988457488,1.0
Defective CUBN causes hereditary megaloblastic anemia 1 ,0.9002100894103349,0.8977895569648512
Formation of HIV elongation complex in the absence of HIV Tat ,0.9003040219156998,0.8412275798303471
Stabilization of p53 ,0.900448869446837,1.0
TWIK related potassium channel (TREK) ,0.9014578375533135,1.0
Cargo concentration in the ER ,0.9018550177466392,0.8159353168527479
PCP/CE pathway ,0.9020241627139278,1.0
PI3K/AKT activation ,0.902036298592678,1.0
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol ,0.9022391293825176,0.8525528158555681
Membrane binding and targetting of GAG proteins ,0.9026565953926234,0.9731319497840216
Activated NTRK2 signals through FRS2 and FRS3 ,0.9028308629726469,1.0
p75NTR negatively regulates cell cycle via SC1 ,0.9032160731518836,1.0
Inhibition of Host mRNA Processing and RNA Silencing ,0.9033372400426954,0.9821561951073772
Conjugation of phenylacetate with glutamine ,0.9035903467924212,0.8758318134464923
FOXO-mediated transcription ,0.9037151853965296,1.0
Mismatch Repair ,0.9044524075290986,0.9759435210283652
Presynaptic function of Kainate receptors ,0.9048144802512752,1.0
RHO GTPases Activate Formins ,0.9056029565930276,1.0
Processive synthesis on the C-strand of the telomere ,0.9066080000997516,0.825010425354462
Inhibition of TSC complex formation by PKB ,0.9066852457697658,1.0
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors ,0.9067933555546132,1.0
Signaling by Non-Receptor Tyrosine Kinases ,0.9073129795891318,0.7456752105070148
ATF6 (ATF6-alpha) activates chaperone genes ,0.9080957982251742,1.0
Activation of BH3-only proteins ,0.9081136273245026,1.0
Tyrosine catabolism ,0.9082478622378906,1.0
Metabolic disorders of biological oxidation enzymes ,0.9090571508925636,1.0
Centrosome maturation ,0.9091427109777016,0.8277784906225274
Toxicity of botulinum toxin type G (BoNT/G) ,0.909206869814328,0.9741028495178354
COPI-independent Golgi-to-ER retrograde traffic ,0.909468376933404,1.0
DARPP-32 events ,0.9096723385795203,1.0
TICAM1 deficiency - HSE ,0.9096754672875832,0.964946071730461
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA ",0.9102339605690832,1.0
mRNA 3'-end processing ,0.9102534903179104,1.0
Regulation of commissural axon pathfinding by SLIT and ROBO ,0.9103068372794636,0.9498727194289158
TP53 Regulates Transcription of Death Receptors and Ligands ,0.9103303660914309,0.9758358767658324
Tat-mediated elongation of the HIV-1 transcript ,0.910571135438118,0.9141456409264426
Toxicity of botulinum toxin type E (BoNT/E) ,0.910613318355976,0.8229788178182674
RNA Polymerase II Transcription Termination ,0.9106530890478952,1.0
Beta-catenin independent WNT signaling ,0.9108571576448772,1.0
"Transport of bile salts and organic acids, metal ions and amine compounds ",0.9111592665626609,1.0
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se ,0.911213260451872,1.0
Viral RNP Complexes in the Host Cell Nucleus ,0.9112760052776784,0.9609216348165472
Activation of Matrix Metalloproteinases ,0.911300639093952,1.0
Erythropoietin activates STAT5 ,0.9113155459146406,1.0
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) ,0.9114214060326444,1.0
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer ,0.9115424666717163,1.0
Nucleotide-like (purinergic) receptors ,0.9115790666750392,1.0
Constitutive Signaling by NOTCH1 PEST Domain Mutants ,0.9117347858069978,1.0
AURKA Activation by TPX2 ,0.9117411409731129,0.8760320110162927
Vitamin B1 (thiamin) metabolism ,0.9117941898484216,0.9665668916856044
Switching of origins to a post-replicative state ,0.9118135788732308,1.0
Receptor Mediated Mitophagy ,0.9118283720484868,1.0
Signaling by BRAF and RAF fusions ,0.9121336145539076,1.0
Selective autophagy ,0.9121788362159756,0.9427188952518032
Mitochondrial Uncoupling Proteins ,0.9121822361580564,1.0
Diseases associated with O-glycosylation of proteins ,0.9122231305033376,1.0
Orc1 removal from chromatin ,0.9123177911895912,1.0
Free fatty acids regulate insulin secretion ,0.9130448608975824,0.9971657279346268
Reactions specific to the complex N-glycan synthesis pathway ,0.9133667863870096,0.9795433282954936
Processing of Capped Intronless Pre-mRNA ,0.913565287302225,1.0
Removal of the Flap Intermediate ,0.9136117082273706,0.8224909646927996
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 ,0.9139093621554212,1.0
COPI-dependent Golgi-to-ER retrograde traffic ,0.9143892779605604,0.8226647704110808
Events associated with phagocytolytic activity of PMN cells ,0.9145223147110833,1.0
Formation of Fibrin Clot (Clotting Cascade) ,0.9145342060324844,1.0
Formyl peptide receptors bind formyl peptides and many other ligands ,0.9148627972054768,0.9648326088269974
Diseases of Cellular Senescence ,0.9150436172937376,1.0
Transport of Mature mRNA derived from an Intron-Containing Transcript ,0.9152771008143388,1.0
Common Pathway of Fibrin Clot Formation ,0.9153868384588416,1.0
"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism ",0.9157499067765512,0.8165157663437479
ARMS-mediated activation ,0.9158849666380742,0.9467509571090512
Transcription of E2F targets under negative control by DREAM complex ,0.9160206868960512,1.0
Translesion synthesis by POLI ,0.9160512448373234,1.0
Erythropoietin activates Phospholipase C gamma (PLCG) ,0.9161060942304822,1.0
PECAM1 interactions ,0.916122941588272,0.9980286382589904
CS/DS degradation ,0.9162281839484044,0.8288626302804785
Formation of the HIV-1 Early Elongation Complex ,0.9163883173919812,0.8826176106761787
Retrograde transport at the Trans-Golgi-Network ,0.9165898422070412,1.0
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects ,0.9165934410855441,1.0
Thrombin signalling through proteinase activated receptors (PARs) ,0.91660541448683,1.0
Sialic acid metabolism ,0.9166531381043552,1.0
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants ,0.9166805363924464,1.0
Rhesus glycoproteins mediate ammonium transport. ,0.9167966333205078,0.9866080596219612
NOTCH4 Intracellular Domain Regulates Transcription ,0.9168660407146556,1.0
Formation of the Early Elongation Complex ,0.9169729916586034,0.9016666251643402
Opsins ,0.9171354635316752,0.9596020684759516
Golgi Cisternae Pericentriolar Stack Reorganization ,0.9171365431164388,1.0
MAPK6/MAPK4 signaling ,0.9171537430608973,1.0
Regulation of necroptotic cell death ,0.9172388150433948,0.978853053848436
Receptor-type tyrosine-protein phosphatases ,0.9176022791473248,1.0
Anchoring fibril formation ,0.9176034454391137,0.9652014910917104
Histidine catabolism ,0.9180232155181296,1.0
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes ,0.9180328948350476,0.9876083983947296
O-linked glycosylation ,0.9180799015874768,1.0
Erythrocytes take up oxygen and release carbon dioxide ,0.9180937746184508,0.9442566491689706
SUMOylation of intracellular receptors ,0.9182784706176956,0.9647475575397572
Fructose biosynthesis ,0.9184050117291436,0.9876597111313355
Fatty acid metabolism ,0.9184737133733846,0.1812932688662464
TRAF6-mediated induction of TAK1 complex within TLR4 complex ,0.9185766531675642,1.0
FGFR2 ligand binding and activation ,0.9188843113208242,0.9698316864991292
Formation of tubulin folding intermediates by CCT/TriC ,0.919084210137312,0.8159593495543009
Nuclear import of Rev protein ,0.9193544932609796,0.8330476315414013
NF-kB is activated and signals survival ,0.9195342295430604,1.0
PI3K events in ERBB4 signaling ,0.91955721939709,1.0
ARL13B-mediated ciliary trafficking of INPP5E ,0.9196427156636148,0.923703452510792
trans-Golgi Network Vesicle Budding ,0.9196571133125836,0.8081386503404852
ER Quality Control Compartment (ERQC) ,0.9197265771407572,1.0
Platelet degranulation  ,0.9199300046578552,0.8223157771833802
Regulation of HSF1-mediated heat shock response ,0.9199648533920656,0.8320257454364308
MAP3K8 (TPL2)-dependent MAPK1/3 activation ,0.9201923380036129,0.9211846469269068
SLC-mediated transmembrane transport ,0.9202006588178492,0.8346079127853574
Interaction between PHLDA1 and AURKA ,0.9202565477948756,0.9804069293914978
WNT mediated activation of DVL ,0.92027974395541,1.0
SDK interactions ,0.9203231431357682,0.9882610887631476
Biosynthesis of maresin-like SPMs ,0.920565239621519,0.9882663942575748
Toxicity of botulinum toxin type A (BoNT/A) ,0.9211620499978606,0.8298326352841235
Glutamate Neurotransmitter Release Cycle ,0.9213916374291962,0.8446827219881224
Integration of provirus ,0.9214338510732109,1.0
Enzymatic degradation of dopamine by COMT ,0.921585341971634,0.9118630106829352
Phase I - Functionalization of compounds ,0.9218112198172512,0.8260776704672259
Dopamine clearance from the synaptic cleft ,0.9218864739146272,0.9111071869360542
CASP8 activity is inhibited ,0.9221878062031296,0.9955150676203912
Nuclear signaling by ERBB4 ,0.9223602808414476,0.907480834393429
NTRK2 activates RAC1 ,0.9225709930203964,0.9827778040930748
Activated NTRK2 signals through PLCG1 ,0.922733334376428,1.0
Processive synthesis on the lagging strand ,0.922870456198894,0.8312422899578863
Signaling by NOTCH1 in Cancer ,0.9229211670605736,1.0
DNA Replication ,0.9229472028349274,1.0
Regulation by c-FLIP ,0.9231861556362808,0.9988268958303004
TGFBR2 Kinase Domain Mutants in Cancer ,0.9232345893510449,0.974650557409506
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects ,0.9237364520836534,1.0
"Adrenaline,noradrenaline inhibits insulin secretion ",0.9238794850208252,1.0
Glycerophospholipid catabolism ,0.9240713623243546,1.0
Signaling by NOTCH1 PEST Domain Mutants in Cancer ,0.924211276300655,1.0
Modulation by Mtb of host immune system ,0.9242700408350244,0.9996651500310046
TWIK-releated acid-sensitive K+ channel (TASK) ,0.924458149126972,1.0
Uptake and actions of bacterial toxins ,0.925039089234557,0.9572517970541964
RIPK1-mediated regulated necrosis ,0.9252339233062684,0.9844235845350296
Hedgehog ligand biogenesis ,0.9253597284127902,1.0
Regulation of localization of FOXO transcription factors ,0.9253923571722449,1.0
Loss of proteins required for interphase microtubule organization from the centrosome ,0.925758278579644,0.8247045800895022
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase ,0.9259803146239456,1.0
PERK regulates gene expression ,0.9262599352188224,0.9764493846165556
"TICAM1,TRAF6-dependent induction of TAK1 complex ",0.9263034486185446,0.9990840946154832
Metabolism of vitamins and cofactors ,0.9263669578140084,0.8382106036597986
p53-Dependent G1/S DNA damage checkpoint ,0.9264909540297676,0.9670332865987544
Signaling by Ligand-Responsive EGFR Variants in Cancer ,0.9265626896588705,1.0
RET signaling ,0.9267525967592688,1.0
FGFR2c ligand binding and activation ,0.9268417851188636,0.972255307516576
Defective Mismatch Repair Associated With MSH6 ,0.9268894790329186,1.0
Glycosphingolipid metabolism ,0.9269436636451556,0.9659294076340684
Transport of inorganic cations/anions and amino acids/oligopeptides ,0.927100119023242,1.0
Invadopodia formation ,0.9271022148526229,1.0
Defective Mismatch Repair Associated With MSH3 ,0.9271140515742012,1.0
Neurotransmitter release cycle ,0.9273672729242272,0.8296612710950241
Tachykinin receptors bind tachykinins ,0.9274907136539292,0.977695542794118
Caspase activation via extrinsic apoptotic signalling pathway ,0.9277373226134832,1.0
TGFBR2 MSI Frameshift Mutants in Cancer ,0.9280153227057509,0.9809064685827661
Calmodulin induced events ,0.9280709054691464,0.8919447564887392
Regulated Necrosis ,0.9281267239954408,0.9830416779958064
Removal of the Flap Intermediate from the C-strand ,0.9283102802630688,0.8300711313979342
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) ,0.9283193121228456,0.9643932023754326
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) ,0.9283611893760346,0.9654410699034234
Activated NTRK2 signals through FYN ,0.9284543648350151,0.9776677242690588
Gamma-carboxylation of protein precursors ,0.9286549609678746,0.989566456341663
IkBA variant leads to EDA-ID ,0.9287352697666702,0.8352004117023354
Ligand-receptor interactions ,0.9288068700797132,1.0
Rev-mediated nuclear export of HIV RNA ,0.9290411976277536,0.8920202566046265
Cell junction organization ,0.9292944087711452,0.8674341350963598
WNT5A-dependent internalization of FZD4 ,0.9293069884807325,1.0
Post-translational protein modification ,0.9295673915837642,0.20624879707448515
Beta oxidation of myristoyl-CoA to lauroyl-CoA ,0.9296069283488791,0.8154475161854501
Urea cycle ,0.929748671745484,1.0
Early Phase of HIV Life Cycle ,0.9299665972051656,1.0
Disease ,0.9300507720047456,1.0
G protein gated Potassium channels ,0.9301299545999951,0.96512389071559
Clathrin-mediated endocytosis ,0.9301974325522084,0.6706590427920703
COPI-mediated anterograde transport ,0.9304599588338596,1.0
HDL assembly ,0.9309151166130724,0.961823083787466
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors ,0.9310150997930844,0.840912352322743
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus ,0.9311256813881551,1.0
The fatty acid cycling model ,0.9320132050879648,1.0
Antigen processing: Ubiquitination & Proteasome degradation ,0.9324917493855388,0.8303743607679683
Ca-dependent events ,0.9329147478953824,0.9633851824728091
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 ,0.9330000156778158,0.96384817573308
Release of apoptotic factors from the mitochondria ,0.9333783496305212,0.8689121951518787
Mitochondrial iron-sulfur cluster biogenesis ,0.9334191817515785,0.9642872350512198
Apoptotic cleavage of cell adhesion  proteins ,0.9334808732407588,0.8320536077865999
APOBEC3G mediated resistance to HIV-1 infection ,0.9335008941300774,1.0
MET activates PTPN11 ,0.9335545832936452,1.0
Cross-presentation of particulate exogenous antigens (phagosomes) ,0.9340518835356872,0.9580084406301764
Signaling by NOTCH1 HD Domain Mutants in Cancer ,0.9343613992913572,1.0
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 ,0.934524435921352,1.0
NRIF signals cell death from the nucleus ,0.9348706898109288,1.0
Defects in biotin (Btn) metabolism ,0.9351893813350106,0.8340971577718641
Serine biosynthesis ,0.935200746726,0.9651478511646612
Lipophagy ,0.9357407139967916,0.8380626186908008
TWIK-related alkaline pH activated K+ channel (TALK) ,0.9363968254084652,1.0
NR1D1 (REV-ERBA) represses gene expression ,0.9364947008693824,1.0
Synthesis of DNA ,0.9369813297546083,1.0
Defective ABCC6 causes pseudoxanthoma elasticum (PXE) ,0.937597807067374,1.0
Regulation of TP53 Expression ,0.9388454481474756,0.9679327094923424
Cyclin A/B1/B2 associated events during G2/M transition ,0.9401419359033456,0.9704487401477886
Conjugation of benzoate with glycine ,0.941187460145214,0.8203247640920062
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) ,0.9417148846855752,1.0
Amine ligand-binding receptors ,0.9421181698141916,1.0
Ca2+ activated K+ channels ,0.9435427245613378,1.0
FRS-mediated FGFR3 signaling ,0.9445158409967424,0.9960873509752894
SUMOylation of RNA binding proteins ,0.94504396189114,0.9631706214275022
Downstream signaling of activated FGFR1 ,0.9453306909689716,1.0
FGFR3b ligand binding and activation ,0.945716503125375,1.0
Post-chaperonin tubulin folding pathway ,0.945870072460615,0.9600455528292088
"Glutamate binding, activation of AMPA receptors and synaptic plasticity ",0.9459060496107378,0.829270118260944
Nicotinate metabolism ,0.9461303687600876,1.0
TICAM1-dependent activation of IRF3/IRF7 ,0.9467081689268672,0.95848933368494
mRNA Editing: A to I Conversion ,0.946906600111862,1.0
G beta:gamma signalling through PI3Kgamma ,0.9469161076016024,1.0
Chylomicron remodeling ,0.947095908742968,0.8212079500116558
Biotin transport and metabolism ,0.9477315153952952,0.8263106882650014
Proton-coupled monocarboxylate transport ,0.948427374521212,1.0
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling ,0.9496145228052884,0.963544863729495
Toxicity of botulinum toxin type F (BoNT/F) ,0.9496884928338276,0.8382263311432226
Regulation of TLR by endogenous ligand ,0.9501505832773204,1.0
Formation of editosomes by ADAR proteins ,0.9502736585749676,1.0
"Biosynthesis of A2E, implicated in retinal degradation ",0.950638524652909,0.9596440256990716
Cellular response to heat stress ,0.9511092423335532,0.9656534256529272
Beta-oxidation of very long chain fatty acids ,0.9512785167758006,0.6654216509095575
Biosynthesis of DPAn-3-derived protectins and resolvins ,0.951389765307468,0.9721868631240148
G1/S DNA Damage Checkpoints ,0.9516054383984148,0.9640407684490064
Visual phototransduction ,0.9516634142835819,1.0
Nef mediated downregulation of CD28 cell surface expression ,0.951849885436985,1.0
p53-Dependent G1 DNA Damage Response ,0.9523092804216242,0.9687938208580409
Alanine metabolism ,0.9524207269234828,0.9649420526815892
Glycerophospholipid biosynthesis ,0.952614254146636,0.8393339617333971
DNA Replication Pre-Initiation ,0.9528700670714544,1.0
CaM pathway ,0.9528770125711891,0.9170978911255432
DAG and IP3 signaling ,0.953394750162492,0.9673356590711224
HSF1 activation ,0.9535865544380814,0.9630825053127142
Biosynthesis of maresin conjugates in tissue regeneration (MCTR) ,0.9540178741215206,0.8566381460015325
N-glycan trimming in the ER and Calnexin/Calreticulin cycle ,0.9540466965222874,1.0
Loss of Nlp from mitotic centrosomes ,0.9541272130255306,0.8804760319955274
Dimerization of procaspase-8 ,0.9551197265392832,0.9960819085812458
Ras activation upon Ca2+ influx through NMDA receptor ,0.9552772756393128,1.0
RHO GTPases Activate Rhotekin and Rhophilins ,0.9558217246663446,1.0
Energy dependent regulation of mTOR by LKB1-AMPK ,0.9560390273594438,0.8245058673084399
Mineralocorticoid biosynthesis ,0.9561012486240942,1.0
Defective CP causes aceruloplasminemia (ACERULOP) ,0.9562504527685264,0.9612240526819602
Trafficking of AMPA receptors ,0.9562778398816959,0.8206891252549455
Toxicity of botulinum toxin type D (BoNT/D) ,0.9567537767350828,0.846021894040633
DCC mediated attractive signaling ,0.9568487733024228,1.0
Response to elevated platelet cytosolic Ca2+ ,0.957148436157516,0.8329590898398238
Transmission across Electrical Synapses  ,0.9576931826513538,0.8650700980976209
Lipid particle organization ,0.9578116343679404,0.8986881331449587
CDC6 association with the ORC:origin complex ,0.9580527902204304,1.0
Chylomicron clearance ,0.9581337390519996,0.926700128534991
rRNA modification in the mitochondrion ,0.9583935928787832,1.0
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein ",0.958402128390989,1.0
Neurodegenerative Diseases ,0.9586004312100233,1.0
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB ,0.9586160489864148,1.0
Constitutive Signaling by NOTCH1 HD Domain Mutants ,0.9588480374765987,1.0
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3) ,0.9590371211075268,0.9118055275037946
Protein ubiquitination ,0.9590559597793176,0.9646300713806388
SHC-mediated cascade:FGFR3 ,0.9593979722306026,0.9830211849139292
Calcineurin activates NFAT ,0.9594907750804746,0.9643207869067548
Mitotic Metaphase/Anaphase Transition ,0.959819654448413,1.0
The proton buffering model ,0.960012678453077,1.0
Tight junction interactions ,0.9602457811503168,0.9573083943824168
RUNX3 regulates BCL2L11 (BIM) transcription ,0.9607684345732652,1.0
Defective CHST3 causes SEDCJD ,0.9640081225772228,0.91850089356463
Acyl chain remodelling of PI ,0.9641968307123444,1.0
Activation of BAD and translocation to mitochondria  ,0.9647290642125306,0.9629138427192696
WNT ligand biogenesis and trafficking ,0.9648015760588876,0.923735583304355
cGMP effects ,0.9648837194351264,1.0
Orexin and neuropeptides FF and QRFP bind to their respective receptors ,0.9650971881458872,0.9651586945164928
Diseases associated with N-glycosylation of proteins ,0.9655956922150208,1.0
FGFR2 mutant receptor activation ,0.9657085145046762,1.0
TP53 Regulates Transcription of Cell Cycle Genes ,0.9657107701885528,0.8261647042588709
Negative regulation of FGFR4 signaling ,0.9658413799976544,0.9682282847825382
Biosynthesis of DHA-derived sulfido conjugates ,0.9660171868684224,0.9266666938619
Synthesis of PIPs at the early endosome membrane ,0.9660533719610704,0.9804202274868102
Biosynthesis of DPAn-3 SPMs ,0.9661808911644516,0.881667576276097
SMAC (DIABLO) binds to IAPs  ,0.9664190082339832,1.0
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes  ,0.9665768433315348,1.0
Cell Cycle Checkpoints ,0.9666645270128488,0.8212155746559416
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) ,0.9666963330804854,0.9179073729532444
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion ,0.966814465084596,1.0
Sodium/Proton exchangers ,0.9668167112905864,0.9824903495930908
Plasma lipoprotein remodeling ,0.9668886177380891,0.8266482673221871
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells ,0.9678020396143112,0.9724879517464836
mRNA Editing ,0.96789250696276,0.9672885827525696
Sphingolipid metabolism ,0.968524768755586,0.864813294898711
Cytosolic sulfonation of small molecules ,0.9685379386340728,0.8374624865450553
Nectin/Necl  trans heterodimerization ,0.9690981371143352,1.0
tRNA processing in the nucleus ,0.969132904049428,0.8907503744759429
Golgi-to-ER retrograde transport ,0.9693214878967806,0.8226002265863069
DNA strand elongation ,0.9695948080449596,0.895710528004106
Notch-HLH transcription pathway ,0.9697972211210122,1.0
Activation of GABAB receptors ,0.9698496114211584,0.8291165493791246
Hyaluronan biosynthesis and export ,0.9699244431856648,1.0
Aryl hydrocarbon receptor signalling ,0.9699680611159228,0.801679220587633
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template ,0.9699694994908304,0.9658549275150198
EPHB-mediated forward signaling ,0.9699833337483588,0.9673717681401168
Effects of PIP2 hydrolysis ,0.9700302579536942,0.8640159667318362
Aquaporin-mediated transport ,0.9703792449295244,0.8191441585936999
PI-3K cascade:FGFR2 ,0.9703845616458564,1.0
Threonine catabolism ,0.9706583241789336,0.837843952281422
"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia ",0.9708208342238092,0.996072826871423
Glycogen storage disease type XV (GYG1) ,0.9708820436569976,0.9412419279549934
5-Phosphoribose 1-diphosphate biosynthesis ,0.9711052364374724,0.8868454481298519
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits ,0.9711975118964372,0.9660662685541728
Acyl chain remodelling of PE ,0.9714965378250102,0.9747485649806212
Biosynthesis of electrophilic -3 PUFA oxo-derivatives ,0.9715082709512862,0.9685063263044914
Free fatty acid receptors ,0.9718701496737436,1.0
The AIM2 inflammasome ,0.9719582254002712,0.9806962125108604
Neurofascin interactions ,0.9726630343001518,1.0
Phospholipase C-mediated cascade; FGFR3 ,0.97283198347002,0.9728615517413874
"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) ",0.9733220035593081,1.0
Loss of Function of SMAD4 in Cancer ,0.9738489491297491,1.0
Transport of small molecules ,0.9740355046654904,0.22986188123802806
Recognition of DNA damage by PCNA-containing replication complex ,0.9757234446872582,0.8776747234547578
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants ,0.9759081872600168,1.0
C6 deamination of adenosine ,0.9764628018678422,1.0
Activation of G protein gated Potassium channels ,0.976767776023058,0.9568373958937524
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models ,0.9768779451836952,1.0
FOXO-mediated transcription of cell death genes ,0.9769905638754399,1.0
Processing of Intronless Pre-mRNAs ,0.9774267312312516,1.0
SMAD4 MH2 Domain Mutants in Cancer ,0.9777233124922836,1.0
PTK6 Regulates Cell Cycle ,0.9780069215536592,0.9996709573440182
ATP sensitive Potassium channels ,0.9780488953551032,0.8777062041299535
IL-6-type cytokine receptor ligand interactions ,0.9784024087223796,0.9728790047023992
SMAD2/3 MH2 Domain Mutants in Cancer ,0.9785824827626702,1.0
Dissolution of Fibrin Clot ,0.9788388745523716,1.0
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA ,0.9789947559893724,0.7971535461110106
Signaling by ERBB4 ,0.9803612297715804,0.8933561930173577
KSRP (KHSRP) binds and destabilizes mRNA ,0.9803745761561524,1.0
Myoclonic epilepsy of Lafora ,0.9805542988915348,0.9680021366280342
ERBB2 Activates PTK6 Signaling ,0.9807737451273872,1.0
SHC-mediated cascade:FGFR2 ,0.980915707435798,0.9798683265121124
Sodium/Calcium exchangers ,0.9811762579195928,0.9581763264258676
RHO GTPases Activate WASPs and WAVEs ,0.9813332564890308,0.8786105628794442
STING mediated induction of host immune responses ,0.9816073031862276,0.8141975756028421
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function ,0.9817195668416392,0.9856722398546468
GABA B receptor activation ,0.9817662826449972,0.8220876489595045
RUNX1 regulates transcription of genes involved in BCR signaling ,0.982172105144724,1.0
Signaling by FGFR2 ,0.9821765194536008,1.0
Enzymatic degradation of Dopamine by monoamine oxidase ,0.9821819789590992,1.0
Diseases associated with glycosaminoglycan metabolism ,0.9823125801883206,1.0
Post-translational protein phosphorylation ,0.982481695491769,0.8486235965868992
Sphingolipid de novo biosynthesis ,0.9826642398711528,1.0
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids ,0.9826850170056236,0.6390929406984452
ChREBP activates metabolic gene expression ,0.9828470838223172,1.0
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2 ",0.9831150263205632,1.0
LGI-ADAM interactions ,0.983152093387481,0.985250955132458
Biosynthesis of DPA-derived SPMs ,0.983786995754962,0.8788021997588021
Postsynaptic nicotinic acetylcholine receptors ,0.9838838075355696,0.8907076681984033
"SMAC, XIAP-regulated apoptotic response ",0.9840078171949226,1.0
MET interacts with TNS proteins ,0.9842292502182796,0.9914986412002532
Synthesis of bile acids and bile salts ,0.9846964080340012,0.8280782154380523
Defective ABCC8 can cause hypoglycemias and hyperglycemias ,0.9849661611046462,0.9940134599468868
Dual Incision in GG-NER ,0.9850820173096504,0.912468284694102
Degradation of GABA ,0.9852153502080828,0.9686442091297848
VxPx cargo-targeting to cilium ,0.9852913672103812,0.9626787175679544
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 ,0.9853967970526764,0.9771001490120008
Downregulation of ERBB4 signaling ,0.9854717229073412,1.0
Activation of ATR in response to replication stress ,0.9856335825465896,0.9810634933071878
"Defective CHST14 causes EDS, musculocontractural type ",0.9858545523914756,0.9651500197557952
Platelet Adhesion to exposed collagen ,0.9859123734884874,1.0
Activation of caspases through apoptosome-mediated cleavage ,0.9859265703299562,0.9667979257260976
Activation of AMPK downstream of NMDARs ,0.9859670154296922,0.8342333525548336
"Formation of the active cofactor, UDP-glucuronate ",0.9861636968078868,1.0
Acyl chain remodelling of PG ,0.9861752551563976,0.9640986690185334
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon ,0.9864599863890128,0.9962842709651164
Metabolism of Angiotensinogen to Angiotensins ,0.986488855816176,0.8383849411270974
Nucleobase biosynthesis ,0.9867520923136373,0.8322270105724708
MicroRNA (miRNA) biogenesis ,0.9867667877997188,1.0
mRNA Splicing - Minor Pathway ,0.9867684540938084,1.0
Synthesis of Ketone Bodies ,0.986987236595902,0.7089323520516182
Metabolism of porphyrins ,0.98717873300782,0.9797114231862756
RUNX1 regulates transcription of genes involved in WNT signaling ,0.9873314607631898,1.0
Interaction between L1 and Ankyrins ,0.9874137095679076,0.9641611012361146
FGFR2 alternative splicing ,0.987493210085346,1.0
Cell-cell junction organization ,0.9875259528224312,0.9211101830179372
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known ,0.987629459376384,1.0
tRNA modification in the mitochondrion ,0.9876543591344188,0.9802447717798138
Beta oxidation of hexanoyl-CoA to butanoyl-CoA ,0.9878782436712316,0.8348039205541424
Diseases of Programmed Cell Death ,0.9878884552991322,0.9855301484896168
Toxicity of botulinum toxin type C (BoNT/C) ,0.9881037684152132,1.0
Metabolism of serotonin ,0.9882293574607102,1.0
Myogenesis ,0.9887312638336218,1.0
Signaling by BMP ,0.9888549855207841,1.0
Translocation of SLC2A4 (GLUT4) to the plasma membrane ,0.9892622487718216,0.4765812678656715
Glycogen storage disease type 0 (muscle GYS1) ,0.9895194448723318,0.9251568516923234
Hydrolysis of LPC ,0.9896229661718652,0.9640760499809709
Extension of Telomeres ,0.9898600838446951,0.9833692857045652
Biosynthesis of DPAn-3-derived 13-series resolvins ,0.9900790244792296,0.9807878281452884
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation ,0.9905230537551284,1.0
Signaling by NOTCH1 ,0.9905613883105197,1.0
Melanin biosynthesis ,0.9906345730826434,0.9818922926341987
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane ,0.9907057113887456,0.8352089070743506
Phenylalanine and tyrosine metabolism ,0.9911280489864972,1.0
CREB phosphorylation ,0.9912993770386824,0.9993643316054848
HCN channels ,0.9916743035956592,1.0
Pyrophosphate hydrolysis ,0.9919530734355168,0.8372957692508727
Pyruvate metabolism ,0.991986339280961,0.8243893998689663
Fibronectin matrix formation ,0.9921364070872812,0.953904087762624
FRS-mediated FGFR4 signaling ,0.9922130299955276,0.988091301782198
Aspartate and asparagine metabolism ,0.9922288023852464,0.8219802006290747
"XAV939 inhibits tankyrase, stabilizing AXIN ",0.9922669968203964,0.9736676070940129
Acetylcholine binding and downstream events ,0.9923491120118076,1.0
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis ,0.9923516731502332,0.976254962001362
MHC class II antigen presentation ,0.9924168492485124,1.0
RUNX3 regulates WNT signaling ,0.992473104293586,1.0
Intra-Golgi and retrograde Golgi-to-ER traffic ,0.992774930099942,0.8281783829919935
Signaling by FGFR2 in disease ,0.9927942874353184,1.0
Mitochondrial calcium ion transport ,0.9928816626340614,1.0
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 ,0.993087602000068,0.9900948610880538
Long-term potentiation ,0.9931816413343733,1.0
Glutamate and glutamine metabolism ,0.9932612972599598,0.9378290215827032
p75NTR recruits signalling complexes ,0.9933057277740464,1.0
SHC-mediated cascade:FGFR1 ,0.9933384030329389,0.988445683566894
Uptake and function of diphtheria toxin ,0.993396258502612,1.0
Apoptotic cleavage of cellular proteins ,0.993785908089482,0.9774673554334408
Vitamins B6 activation to pyridoxal phosphate ,0.9940048892146492,1.0
Signaling by FGFR ,0.9942110771825748,0.9651146613113007
Retrograde neurotrophin signalling ,0.9946656156189888,1.0
Calcitonin-like ligand receptors ,0.9947819608407464,0.9815402381669144
Downstream signaling of activated FGFR4 ,0.9948370490698901,1.0
Synthesis of PC ,0.9948699175050492,0.8109859491131595
Sperm Motility And Taxes ,0.994904420700328,0.9996850635051758
Tandem pore domain potassium channels ,0.994970516472106,1.0
O-linked glycosylation of mucins ,0.995061577089016,1.0
"GABA synthesis, release, reuptake and degradation ",0.9952998814600544,0.8345545541067805
Transferrin endocytosis and recycling ,0.9954866097952352,0.8283041444170864
Resolution of AP sites via the multiple-nucleotide patch replacement pathway ,0.9956060257803508,0.9759259113464206
Signalling to p38 via RIT and RIN ,0.9956914845573759,0.9643554008845696
Plasma lipoprotein assembly ,0.9957586156323116,0.9724638945769324
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) ,0.995788159056129,0.9683464375304874
Frs2-mediated activation ,0.9958240830538266,1.0
Synthesis of PIPs in the nucleus ,0.9958957565273102,1.0
Metabolism of nitric oxide: eNOS activation and regulation ,0.9959848169680924,0.9625989229335156
PI5P Regulates TP53 Acetylation ,0.9962922310143112,1.0
p130Cas linkage to MAPK signaling for integrins ,0.9963269903934634,1.0
Metabolism of vitamin K ,0.9964426276144732,1.0
The retinoid cycle in cones (daylight vision) ,0.9965657466201522,1.0
Apoptotic execution phase ,0.996599626830758,0.9374949365908984
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes ",0.9966484939247208,1.0
Activation of AMPA receptors ,0.9968382702337364,0.8785955072533241
Transport of connexons to the plasma membrane ,0.9968722066902228,0.8708388030459309
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD) ,0.9969291614165088,1.0
Signaling by FGFR2 IIIa TM ,0.997042004971562,1.0
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 ,0.9971036403853368,0.9614864358523292
Inhibition of nitric oxide production ,0.9971537731472128,0.9803688502466836
Beta oxidation of octanoyl-CoA to hexanoyl-CoA ,0.9971748110613264,0.7740284602037212
SHC-mediated cascade:FGFR4 ,0.9973496096121776,0.9650211041648352
FOXO-mediated transcription of cell cycle genes ,0.997382595700398,1.0
NOTCH2 Activation and Transmission of Signal to the Nucleus ,0.9974050032596216,1.0
Bile acid and bile salt metabolism ,0.9975312958891804,0.8388439796696677
mitochondrial fatty acid beta-oxidation of saturated fatty acids ,0.9975438734262568,0.8259563622365959
Release of Hh-Np from the secreting cell ,0.9976128347501928,0.9752638895882434
Endosomal/Vacuolar pathway ,0.9977052557334825,0.9725662953147124
Basigin interactions ,0.9977479103898932,0.9697425369267288
RHO GTPases activate PAKs ,0.9977569189005364,1.0
Potassium transport channels ,0.9977967187157556,0.829159650696724
Muscarinic acetylcholine receptors ,0.9978051160025904,0.8385853080823951
Nef mediated downregulation of MHC class I complex cell surface expression ,0.9978610169876909,1.0
Keratan sulfate/keratin metabolism ,0.9978656982143128,1.0
Attenuation phase ,0.9978758935477808,1.0
Insulin receptor recycling ,0.9979182688442174,0.7973903302061383
Sema4D induced cell migration and growth-cone collapse ,0.9979259503021872,1.0
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation ,0.9980347208580884,0.9707751977745609
Signaling by ERBB2 ,0.9980456352785392,1.0
Loss of MECP2 binding ability to the NCoR/SMRT complex ,0.998088620298556,0.982086470660282
Neurotoxicity of clostridium toxins ,0.998090102713104,0.8118373770066273
Interleukin-33 signaling ,0.9983298970713184,0.9787383184964128
AKT phosphorylates targets in the cytosol ,0.9983908954045996,0.9826541061493186
Apoptosis induced DNA fragmentation ,0.998410048136956,0.8939927210832371
Suppression of apoptosis ,0.9985610542863921,1.0
Phase 2 - plateau phase ,0.9985735693080412,1.0
Miscellaneous substrates ,0.9985778803302012,1.0
Synthesis of PIPs at the late endosome membrane ,0.9986055335248768,0.8323658344762194
RUNX3 regulates p14-ARF ,0.9986122476139144,1.0
FGFR2b ligand binding and activation ,0.9986151315603446,0.8298317249486235
Transcriptional Regulation by VENTX ,0.9986920721258942,1.0
Loss of phosphorylation of MECP2 at T308 ,0.9987609232778282,0.9645708293604528
AKT-mediated inactivation of FOXO1A ,0.9987848998288226,1.0
Multifunctional anion exchangers ,0.9988063895485118,1.0
CRMPs in Sema3A signaling ,0.9988075684987384,0.9162724482136876
Synthesis of Lipoxins (LX) ,0.9988348803443364,0.8230113664601324
Signaling by activated point mutants of FGFR1 ,0.9989063293860012,1.0
InlB-mediated entry of Listeria monocytogenes into host cell ,0.9989395204163052,0.9793817121798772
Activation of TRKA receptors ,0.99900910925499,1.0
Catecholamine biosynthesis ,0.9990872395718456,1.0
NR1H2 and NR1H3-mediated signaling ,0.9991220148203788,0.8813942719578368
SMAD2/3 Phosphorylation Motif Mutants in Cancer ,0.9991336477340684,1.0
Intra-Golgi traffic ,0.9991357563570336,0.7932157674130151
Axonal growth inhibition (RHOA activation) ,0.9991501479823568,0.8261227304805288
Inactivation of CDC42 and RAC1 ,0.9991857693181684,1.0
Vitamin C (ascorbate) metabolism ,0.9992532121932844,0.9968357330742652
Gastrin-CREB signalling pathway via PKC and MAPK ,0.9992968721639284,1.0
Signaling by TGF-beta Receptor Complex in Cancer ,0.9993607820930436,1.0
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) ,0.9993627084318912,0.8243231788414087
Noncanonical activation of NOTCH3 ,0.99936719051427,0.965393592612918
Negative regulation of NMDA receptor-mediated neuronal transmission ,0.9993810138892985,1.0
TGFBR1 KD Mutants in Cancer ,0.9993886630661928,1.0
TGFBR1 LBD Mutants in Cancer ,0.99940543607075,0.92199602818084
Acyl chain remodelling of PC ,0.9994292883122844,1.0
Beta oxidation of butanoyl-CoA to acetyl-CoA ,0.9994372588044752,0.7895999772477593
Transport of connexins along the secretory pathway ,0.9995261893456382,0.9865843533845856
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) ,0.9995549178832389,0.9846639230735098
EGFR Transactivation by Gastrin ,0.9995732878148308,1.0
Carnitine metabolism ,0.999614647603618,0.674719436187326
p75NTR signals via NF-kB ,0.999637844812904,0.9814693880018824
InlA-mediated entry of Listeria monocytogenes into host cells ,0.9996423655783648,1.0
Presynaptic depolarization and calcium channel opening ,0.9996651083796472,1.0
Caspase activation via Dependence Receptors in the absence of ligand ,0.9997132226942888,1.0
Biosynthesis of specialized proresolving mediators (SPMs) ,0.9997253963608396,0.8159460151173675
Biosynthesis of DHA-derived SPMs ,0.9997520809639852,0.8781558736663169
PP2A-mediated dephosphorylation of key metabolic factors ,0.9997547485596564,1.0
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane ,0.9997678147100568,1.0
Alpha-defensins ,0.9997826186993752,1.0
Negative regulation of FGFR3 signaling ,0.9997957553451868,0.9812381206042592
NTF4 activates NTRK2 (TRKB) signaling ,0.9998415433471816,1.0
Synthesis of 12-eicosatetraenoic acid derivatives ,0.999874997300909,1.0
RHO GTPases activate IQGAPs ,0.9999503805346062,0.8252691322681922
Cell-extracellular matrix interactions ,0.999966783269106,1.0
FGFR4 ligand binding and activation ,1.0,0.958195306595396
Formation of xylulose-5-phosphate ,1.0,0.9807244004303712
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane ,1.0,0.9639192502410704
Organic anion transporters ,1.0,1.0
rRNA processing in the mitochondrion ,1.0,1.0
PKA-mediated phosphorylation of key metabolic factors ,1.0,0.9817550490557988
Degradation of cysteine and homocysteine ,1.0,1.0
Ion influx/efflux at host-pathogen interface ,1.0,1.0
FasL/ CD95L signaling ,1.0,0.9642048064066412
Acrosome Reaction and Sperm:Oocyte Membrane Binding ,1.0,1.0
Formation of annular gap junctions ,1.0,0.9890729143143968
Dermatan sulfate biosynthesis ,1.0,1.0
Regulation of thyroid hormone activity ,1.0,0.9135995118079926
Gap junction degradation ,1.0,0.9656332637128446
Assembly of the ORC complex at the origin of replication ,1.0,1.0
Phosphate bond hydrolysis by NTPDase proteins ,1.0,0.8268209262704675
Pentose phosphate pathway disease ,1.0,0.8774005046940826
Spry regulation of FGF signaling ,1.0,1.0
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 ,1.0,0.9804431474119252
"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins ",1.0,1.0
Purine ribonucleoside monophosphate biosynthesis ,1.0,0.8044117271699397
Removal of aminoterminal propeptides from gamma-carboxylated proteins ,1.0,1.0
SUMOylation of DNA methylation proteins ,1.0,0.9861275956459444
Response to metal ions ,1.0,0.9392359464826489
Activation of PPARGC1A (PGC-1alpha) by phosphorylation ,1.0,0.9805888088607866
Condensation of Prometaphase Chromosomes ,1.0,1.0
Polymerase switching on the C-strand of the telomere ,1.0,1.0
"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 ",1.0,0.986848298561548
HSF1-dependent transactivation ,1.0,1.0
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest ,1.0,0.8409008283904029
Metabolism of amine-derived hormones ,1.0,1.0
Fructose metabolism ,1.0,0.9732573081938508
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation ,1.0,0.9641761609763398
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells ,1.0,0.965253953059385
Insulin effects increased synthesis of Xylulose-5-Phosphate ,1.0,0.9200927550110812
Polymerase switching ,1.0,0.9999379884637096
"Unblocking of NMDA receptors, glutamate binding and activation ",1.0,1.0
Phospholipase C-mediated cascade: FGFR1 ,1.0,0.981597425282766
Relaxin receptors ,1.0,1.0
The IPAF inflammasome ,1.0,0.9585341153816892
Linoleic acid (LA) metabolism ,1.0,0.8137902752041986
Defective HLCS causes multiple carboxylase deficiency ,1.0,0.8285628055882611
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis ,1.0,0.9230980188693176
Downregulation of TGF-beta receptor signaling ,1.0,1.0
The NLRP1 inflammasome ,1.0,1.0
Loss of Function of SMAD2/3 in Cancer ,1.0,1.0
PLC-gamma1 signalling ,1.0,1.0
BDNF activates NTRK2 (TRKB) signaling ,1.0,1.0
Glucocorticoid biosynthesis ,1.0,0.9989175128457864
IRAK1 recruits IKK complex ,1.0,0.9764665650947986
Defective Mismatch Repair Associated With MSH2 ,1.0,1.0
PTK6 Expression ,1.0,0.9796353611821016
Metabolism of folate and pterines ,1.0,0.8312006396194199
Lewis blood group biosynthesis ,1.0,1.0
Leading Strand Synthesis ,1.0,0.9989837899302151
alpha-linolenic acid (ALA) metabolism ,1.0,0.6234698787451081
p75NTR regulates axonogenesis ,1.0,0.8237228311153552
Glycogen storage diseases ,1.0,0.965166470801352
"Transport of vitamins, nucleosides, and related molecules ",1.0,1.0
Toxicity of botulinum toxin type B (BoNT/B) ,1.0,0.9233608636203248
Acetylcholine Neurotransmitter Release Cycle ,1.0,0.9573795391574575
Signaling by activated point mutants of FGFR3 ,1.0,0.9681274988649634
GABA synthesis ,1.0,0.9694213554030068
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism ,1.0,0.6178253958070472
FGFR3 mutant receptor activation ,1.0,0.9696354216381068
FGFR3 ligand binding and activation ,1.0,0.9734707366454752
Synthesis of 15-eicosatetraenoic acid derivatives ,1.0,1.0
SHC-related events triggered by IGF1R ,1.0,1.0
"Activation, translocation and oligomerization of BAX ",1.0,1.0
FGFR1 ligand binding and activation ,1.0,0.9805465790440144
FGFR1b ligand binding and activation ,1.0,0.9665597319447436
Synthesis of 5-eicosatetraenoic acids ,1.0,0.8225700904599988
Lagging Strand Synthesis ,1.0,0.9656961197612891
Serotonin clearance from the synaptic cleft ,1.0,1.0
Diseases associated with visual transduction ,1.0,1.0
Interleukin-1 processing ,1.0,0.8520785670015533
Amino acid transport across the plasma membrane ,1.0,0.9827115129487141
Retinoid metabolism and transport ,1.0,1.0
Retinoid cycle disease events ,1.0,1.0
Negative regulation of FGFR1 signaling ,1.0,0.9788187980738876
RUNX1 regulates expression of components of tight junctions ,1.0,0.9623257504582432
PCNA-Dependent Long Patch Base Excision Repair ,1.0,0.9730624155365204
SHC1 events in ERBB2 signaling ,1.0,1.0
Chylomicron assembly ,1.0,0.9744514475295872
FGFR3c ligand binding and activation ,1.0,0.967662172585546
Oligomerization of connexins into connexons ,1.0,0.9879257092164399
FRS-mediated FGFR2 signaling ,1.0,0.9810394263464132
Binding and entry of HIV virion ,1.0,1.0
Loss of Function of TGFBR1 in Cancer ,1.0,1.0
ERKs are inactivated ,1.0,1.0
P2Y receptors ,1.0,1.0
Ubiquinol biosynthesis ,1.0,0.9770942641884192
Constitutive Signaling by Overexpressed ERBB2 ,1.0,0.9914579765263613
Inwardly rectifying K+ channels ,1.0,0.8604593409145727
NOTCH4 Activation and Transmission of Signal to the Nucleus ,1.0,0.9658734343530389
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production ,1.0,1.0
Phase 0 - rapid depolarisation ,1.0,1.0
Prolonged ERK activation events ,1.0,1.0
Role of ABL in ROBO-SLIT signaling ,1.0,0.9827787652600171
HDL clearance ,1.0,0.8266912043670454
Keratan sulfate biosynthesis ,1.0,1.0
Eicosanoids ,1.0,1.0
Interleukin-38 signaling ,1.0,0.9526111334047356
Nicotinamide salvaging ,1.0,1.0
Branched-chain amino acid catabolism ,1.0,0.4682670679334566
Gap-filling DNA repair synthesis and ligation in GG-NER ,1.0,0.9796187077818804
Listeria monocytogenes entry into host cells ,1.0,0.9865938988056882
MET activates RAS signaling ,1.0,0.9831998866788584
Signaling by FGFR4 ,1.0,1.0
Lysosome Vesicle Biogenesis ,1.0,1.0
FGFRL1 modulation of FGFR1 signaling ,1.0,0.9125118142993864
Cytosolic iron-sulfur cluster assembly ,1.0,1.0
Blood group systems biosynthesis ,1.0,1.0
Downstream signaling of activated FGFR2 ,1.0,1.0
Recycling of bile acids and salts ,1.0,0.9995984149802128
NOTCH3 Activation and Transmission of Signal to the Nucleus ,1.0,0.9846895410169684
PIWI-interacting RNA (piRNA) biogenesis ,1.0,1.0
Vitamin B5 (pantothenate) metabolism ,1.0,1.0
TGF-beta receptor signaling activates SMADs ,1.0,0.9805035599386696
Passive transport by Aquaporins ,1.0,0.96370304976068
Reduction of cytosolic Ca++ levels ,1.0,1.0
Purine salvage ,1.0,1.0
Acyl chain remodelling of PS ,1.0,1.0
GRB2 events in ERBB2 signaling ,1.0,1.0
HDL remodeling ,1.0,0.8267861284798476
Synthesis of Leukotrienes (LT) and Eoxins (EX) ,1.0,1.0
Metabolism of fat-soluble vitamins ,1.0,1.0
Negative regulation of MET activity ,1.0,0.9881283117726029
SHC1 events in ERBB4 signaling ,1.0,1.0
Iron uptake and transport ,1.0,0.7946750497209213
Adherens junctions interactions ,1.0,0.972976902153829
"Synthesis of IP2, IP, and Ins in the cytosol ",1.0,1.0
Signaling by ERBB2 in Cancer ,1.0,1.0
Mitochondrial Fatty Acid Beta-Oxidation ,1.0,0.4952581147940026
Inositol transporters ,1.0,0.8409877420817911
FGFR1c ligand binding and activation ,1.0,1.0
Signaling by ERBB2 KD Mutants ,1.0,1.0
Synthesis of PE ,1.0,1.0
Signaling by FGFR1 ,1.0,0.9730598703012276
L1CAM interactions ,1.0,0.9671510487707894
Nuclear Receptor transcription pathway ,1.0,1.0
Reuptake of GABA ,1.0,0.9624902092106072
Signaling by FGFR3 ,1.0,1.0
